| Year |
Citation |
Score |
| 2023 |
Chiang J, Bagchi A, Li X, Dhanda SK, Huang J, Pinto SN, Sioson E, Dalton J, Tatevossian RG, Jia S, Partap S, Fisher PG, Bowers DC, Hassall T, Lu C, ... ... Gajjar A, et al. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse-Results from the SJYC07 trial and institutional experience. Neuro-Oncology. PMID 37503880 DOI: 10.1093/neuonc/noad130 |
0.312 |
|
| 2022 |
Gajjar A, Mahajan A, Abdelbaki M, Anderson C, Antony R, Bale T, Bindra R, Bowers DC, Cohen K, Cole B, Dorris K, Ermoian R, Franson A, Helgager J, Landi D, et al. Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 1339-1362. PMID 36509072 DOI: 10.6004/jnccn.2022.0062 |
0.38 |
|
| 2022 |
Liu APY, Dhanda SK, Lin T, Sioson E, Vasilyeva A, Gudenas B, Tatevossian RG, Jia S, Neale G, Bowers DC, Hassall T, Partap S, Crawford JR, Chintagumpala M, Bouffet E, ... ... Gajjar A, et al. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathologica. PMID 35982322 DOI: 10.1007/s00401-022-02484-7 |
0.332 |
|
| 2022 |
Hansford JR, Huang J, Endersby R, Dodgshun AJ, Li BK, Hwang E, Leary S, Gajjar A, Von Hoff K, Wells O, Wray A, Kotecha RS, Raleigh DR, Stoller S, Mueller S, et al. Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. Neuro-Oncology Advances. 4: vdac056. PMID 35664557 DOI: 10.1093/noajnl/vdac056 |
0.335 |
|
| 2022 |
Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, Whipple NS, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki MS, Armstrong AE, Cash T, ... ... Gajjar A, et al. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1 or ALK aberrations (STARTRK-NG). Neuro-Oncology. PMID 35395680 DOI: 10.1093/neuonc/noac087 |
0.322 |
|
| 2021 |
Liu AP, Northcott PA, Robinson GW, Gajjar A. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 134-142. PMID 34934181 DOI: 10.1038/s41374-021-00719-x |
0.302 |
|
| 2021 |
Liu AP, Northcott PA, Robinson GW, Gajjar A. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 134-142. PMID 34934181 DOI: 10.1038/s41374-021-00719-x |
0.302 |
|
| 2021 |
Liu AP, Northcott PA, Robinson GW, Gajjar A. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 134-142. PMID 34934181 DOI: 10.1038/s41374-021-00719-x |
0.302 |
|
| 2021 |
Leary SES, Packer RJ, Li Y, Billups CA, Smith KS, Jaju A, Heier L, Burger P, Walsh K, Han Y, Embry L, Hadley J, Kumar R, Michalski J, Hwang E, ... Gajjar A, et al. Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. Jama Oncology. PMID 34292305 DOI: 10.1001/jamaoncol.2021.2224 |
0.337 |
|
| 2021 |
Levy AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C, Fouladi M, Gajjar A. Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial. Pediatric Blood & Cancer. e29031. PMID 33844469 DOI: 10.1002/pbc.29031 |
0.317 |
|
| 2021 |
Upadhyaya SA, Robinson G, Onar-Thomas A, Orr BA, Johann P, Wu G, Billups CA, Tatevossian RG, Dhanda SK, Srinivasan A, Broniscer A, Qaddoumi I, Vinitsky A, Armstrong GT, Bendel A, ... ... Gajjar A, et al. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-Institutional Trials. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33737307 DOI: 10.1158/1078-0432.CCR-20-4731 |
0.319 |
|
| 2021 |
Hansford J, Huang J, Dodgshun A, Li B, Hwang E, Leary S, Gajjar A, Von Hoff K, Endersby R, Wells O, Wray A, Kotecha R, Raleigh D, Stoller S, Mueller S, et al. EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA Neuro-Oncology. 23: i6-i6. DOI: 10.1093/neuonc/noab090.021 |
0.346 |
|
| 2020 |
Liu APY, Priesterbach-Ackley LP, Orr BA, Li BK, Gudenas B, Reddingius RE, Suñol M, Lavarino CE, Olaciregui NG, Santa-María López V, Fisher MJ, Hazrati LN, Bouffet E, Huang A, Robinson GW, ... ... Gajjar A, et al. WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? Acta Neuropathologica. PMID 32772175 DOI: 10.1007/S00401-020-02208-9 |
0.343 |
|
| 2020 |
Hersh DS, Kumar R, Moore KA, Smith LGF, Tinkle CL, Chiang J, Patay Z, Gajjar A, Choudhri AF, Lee-Diaz JA, Vaughn B, Klimo P. Safety and efficacy of brainstem biopsy in children and young adults. Journal of Neurosurgery. Pediatrics. 1-11. PMID 32736346 DOI: 10.3171/2020.4.Peds2092 |
0.315 |
|
| 2020 |
Mizumoto M, Oshiro Y, Pan H, Wang F, Kaste SC, Gajjar A, Chemaitilly W, Merchant TE. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors. Pediatric Blood & Cancer. e28617. PMID 32715632 DOI: 10.1002/Pbc.28617 |
0.414 |
|
| 2020 |
Jacola LM, Anghelescu DL, Hall L, Russell K, Zhang H, Wang F, Peters JB, Rossi M, Schreiber JE, Gajjar A. Anesthesia Exposure during Therapy Predicts Neurocognitive Outcomes in Survivors of Childhood Medulloblastoma. The Journal of Pediatrics. PMID 32532646 DOI: 10.1016/J.Jpeds.2020.04.039 |
0.341 |
|
| 2020 |
Nicolaides T, Nazemi KJ, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Long-Boyle J, Wang H, Molinaro AM, Mueller S, et al. Phase I study of vemurafenib in children with recurrent or progressive BRAF mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002). Oncotarget. 11: 1942-1952. PMID 32523649 DOI: 10.18632/Oncotarget.27600 |
0.463 |
|
| 2020 |
Smith KS, Xu K, Mercer KS, Boop F, Klimo P, DeCupyere M, Grenet J, Robinson S, Dunphy P, Baker SJ, Ellison DW, Merchant TE, Upadayaya SA, Gajjar A, Wu G, et al. Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource. Acta Neuropathologica. PMID 32519082 DOI: 10.1007/S00401-020-02171-5 |
0.453 |
|
| 2020 |
Liu APY, Liu Q, Shing MMK, Ku DTL, Fu E, Luk CW, Ling SC, Cheng KKF, Kwong DLW, Ho WWS, Ng HK, Gajjar A, Yasui Y, Chan GCF, Armstrong GT. Incidence and Outcomes of CNS Tumors in Chinese Children: Comparative Analysis With the Surveillance, Epidemiology, and End Results Program. Jco Global Oncology. 6: 704-721. PMID 32392090 DOI: 10.1200/JGO.19.00378 |
0.308 |
|
| 2020 |
Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P, Boop FA, Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z, Tinkle CL. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathologica Communications. 8: 57. PMID 32326973 DOI: 10.1186/S40478-020-00930-9 |
0.376 |
|
| 2020 |
Waszak SM, Robinson GW, Gudenas BL, Smith KS, Forget A, Kojic M, Garcia-Lopez J, Hadley J, Hamilton KV, Indersie E, Buchhalter I, Kerssemakers J, Jäger N, Sharma T, Rausch T, ... ... Gajjar A, et al. Germline Elongator mutations in Sonic Hedgehog medulloblastoma. Nature. 580: 396-401. PMID 32296180 DOI: 10.1038/S41586-020-2164-5 |
0.313 |
|
| 2020 |
Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, et al. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901776. PMID 32105509 DOI: 10.1200/Jco.19.01776 |
0.44 |
|
| 2020 |
Acharya S, Liu JF, Tatevossian RG, Chiang J, Qaddoumi I, Gajjar A, Walker D, Harreld J, Merchant TE, Ellison DW. Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: An integrated clinicopathologic and molecular analysis. Neuro-Oncology. PMID 32052049 DOI: 10.1093/Neuonc/Noaa031 |
0.412 |
|
| 2020 |
Reddick SJ, Campagne O, Huang J, Onar-Thomas A, Broniscer A, Gajjar A, Stewart CF. Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors. Cancer Chemotherapy and Pharmacology. PMID 31912224 DOI: 10.1007/S00280-019-04026-7 |
0.342 |
|
| 2020 |
Desai AV, Robinson GW, Basu EM, Foster J, Gauvain K, Sabnis A, Shusterman S, Macy ME, Maese L, Yoon J, Cash T, Abdelbaki M, Nazemi K, Weiss BD, Chohan S, ... ... Gajjar AJ, et al. Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors. Journal of Clinical Oncology. 38: 107-107. DOI: 10.1200/jco.2020.38.15_suppl.107 |
0.313 |
|
| 2020 |
Sharma T, Schwalbe EC, Williamson DW, Sill M, Hovestadt V, Mynarek M, Rutkowski S, Robinson GW, Gajjar A, Cavalli F, Ramaswamy V, Taylor MD, Lindsey JC, Hill RM, Jäger N, et al. Abstract B73: Second-generation molecular subgrouping of medulloblastoma: An international meta-analysis of Group 3 and Group 4 subtypes Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-B73 |
0.301 |
|
| 2020 |
Benzel J, Sauter M, Mack N, Davis A, Weiss J, Uhl P, Burhenne J, Maass KK, Hübner J, Witt H, Shelat A, Gajjar A, Upadhyaya SA, Camgoz A, Buchholz F, et al. Abstract A25: Evaluation of Drug Disposition in Supratentorial Ependymoma Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A25 |
0.364 |
|
| 2020 |
Dunphy PS, Xu K, Gentry DT, He C, Mercer K, Zhu X, Smith K, Gudenas B, Robinson S, Zhang J, Kasper LH, Kwon C, Hover LD, Larson JD, Twarog N, ... ... Gajjar A, et al. Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors Tumor Biology. DOI: 10.1158/1538-7445.Am2020-6144 |
0.417 |
|
| 2020 |
Guerrini-Rousseau L, Waszak S, Bourdeaut F, Delattre O, Dikow N, Dufour C, Gajjar A, Grill J, Hirsch S, Hopman S, Jones D, Jongmans M, Korshunov A, Kratz C, Lafay-Cousin L, et al. RARE-21. CANCER SPECTRUM IN GERMLINE SUFU MUTATION CARRIERS: A COLLABORATIVE PROJECT OF THE SIOPE HOST GENOME WORKING GROUP Neuro-Oncology. 22: iii446-iii447. DOI: 10.1093/neuonc/noaa222.732 |
0.308 |
|
| 2020 |
Li BK, Burger P, Judkins AR, Ho BLB, Kang G, Gossett J, Leary S, Pollack I, Gajjar A, Fouladi M, Kellie SJ, Mazewski C, Huang A. PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP Neuro-Oncology. 22: iii429-iii429. DOI: 10.1093/neuonc/noaa222.659 |
0.361 |
|
| 2020 |
Liu AP, Kumar R, Kyle S, Paul L, Chintagumpala M, Bouffet E, Fisher MJ, Hassall T, Gururangan S, Hansford J, Cohn R, Ellison DW, Gilbertson RJ, Gajjar A, Robinson GW, et al. MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA Neuro-Oncology. 22: iii401-iii402. DOI: 10.1093/neuonc/noaa222.536 |
0.341 |
|
| 2020 |
Kumar R, Deng M, Smith K, Liu A, Dhall G, Kleese L, Bowers D, Chintagumpala M, Leary S, Nazarian J, Orr B, Onar-Thomas A, Pfister S, Korshunov A, Robinson G, ... Gajjar A, et al. MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS Neuro-Oncology. 22: iii389-iii389. DOI: 10.1093/neuonc/noaa222.484 |
0.304 |
|
| 2020 |
Bartels U, Fangusaro J, Shaw D, Bhatia A, Omar-Thomas A, Wu S, MacDonald S, Murphy E, Souweidane M, Fouladi M, Gajjar A, Dhall G, Khatua S. GCT-41. RESPONSE-BASED RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LOCALIZED GERMINOMA: A CHILDREN’S ONCOLOGY GROUP (COG) PROSPECTIVE PHASE 2 CLINICAL TRIAL Neuro-Oncology. 22: iii336-iii336. DOI: 10.1093/neuonc/noaa222.259 |
0.315 |
|
| 2019 |
Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, ... ... Gajjar A, et al. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathologica. PMID 31820118 DOI: 10.1007/S00401-019-02111-Y |
0.426 |
|
| 2019 |
Liu APY, Gudenas B, Lin T, Orr BA, Klimo P, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, ... ... Gajjar A, et al. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathologica. PMID 31802236 DOI: 10.1007/S00401-019-02106-9 |
0.418 |
|
| 2019 |
Campagne O, Zhong B, Nair S, Lin T, Huang J, Onar-Thomas A, Robinson G, Gajjar A, Stewart CF. Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31796512 DOI: 10.1158/1078-0432.Ccr-19-2685 |
0.393 |
|
| 2019 |
Lafay-Cousin L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas A, Billups CA, Fouladi M, Northcott P, Robinson G, ... Gajjar A, et al. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900845. PMID 31774708 DOI: 10.1200/Jco.19.00845 |
0.378 |
|
| 2019 |
Qaddoumi I, Merchant TE, Boop FA, Gajjar A. Diagnostic delay in children with central nervous system tumors and the need to improve education. Journal of Neuro-Oncology. PMID 31691058 DOI: 10.1007/S11060-019-03329-2 |
0.369 |
|
| 2019 |
Panetta JC, Roberts JK, Huang J, Lin T, Daryani VM, Harstead KE, Patel YT, Onar-Thomas A, Campagne O, Ward DA, Broniscer A, Robinson G, Gajjar A, Stewart CF. Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumors. British Journal of Clinical Pharmacology. PMID 31657864 DOI: 10.1111/Bcp.14160 |
0.384 |
|
| 2019 |
Carey SS, Sadighi Z, Wu S, Chiang J, Robinson GW, Ghazwani Y, Liu APY, Acharya S, Merchant TE, Boop FA, Gajjar A, Qaddoumi I. Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis. Journal of Neuro-Oncology. PMID 31642023 DOI: 10.1007/S11060-019-03319-4 |
0.393 |
|
| 2019 |
Begemann M, Waszak SM, Robinson GW, Jäger N, Sharma T, Knopp C, Kraft F, Moser O, Mynarek M, Guerrini-Rousseau L, Brugieres L, Varlet P, Pietsch T, Bowers DC, Chintagumpala M, ... ... Gajjar A, et al. Germline Mutations Predispose to Pediatric Medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900577. PMID 31609649 DOI: 10.1200/Jco.19.00577 |
0.318 |
|
| 2019 |
Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, Khatua S, Souweidane M, Lu HM, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, Gajjar A, Dhall G. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900701. PMID 31545689 DOI: 10.1200/Jco.19.00701 |
0.439 |
|
| 2019 |
Reddick SJ, Campagne O, Huang J, Onar-Thomas A, Broniscer A, Gajjar A, Stewart CF. Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors. Cancer Chemotherapy and Pharmacology. PMID 31392390 DOI: 10.1007/S00280-019-03921-3 |
0.371 |
|
| 2019 |
Olivier TW, Bass JK, Ashford JM, Beaulieu R, Scott SM, Schreiber JE, Palmer S, Mabbott DJ, Swain MA, Bonner M, Boyle R, Chapeiski ML, Evankovich KD, Armstrong CL, Knight SJ, ... ... Gajjar A, et al. Cognitive Implications of Ototoxicity in Pediatric Patients With Embryonal Brain Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801358. PMID 31046551 DOI: 10.1200/Jco.18.01358 |
0.425 |
|
| 2019 |
Acharya S, Wu S, Ashford JM, Tinkle CL, Lucas JT, Qaddoumi I, Gajjar A, Krasin MJ, Conklin HM, Merchant TE. Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study. Neuro-Oncology. PMID 30977510 DOI: 10.1093/Neuonc/Noz068 |
0.314 |
|
| 2019 |
Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC, Bendel AE, Hassall T, Crawford JR, Partap S, Fisher PG, Tatevossian RG, Seah T, Qaddoumi IA, Vinitsky A, ... ... Gajjar A, et al. Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial. Neuro-Oncology. PMID 30976811 DOI: 10.1093/Neuonc/Noz069 |
0.354 |
|
| 2019 |
Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, et al. Challenges to curing primary brain tumours. Nature Reviews. Clinical Oncology. PMID 30733593 DOI: 10.1038/S41571-019-0177-5 |
0.303 |
|
| 2019 |
Liu APY, Hastings C, Wu S, Bass JK, Heitzer AM, Ashford J, Vestal R, Hoehn ME, Ghazwani Y, Acharya S, Conklin HM, Boop F, Merchant TE, Gajjar A, Qaddoumi I. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life. Cancer. PMID 30620400 DOI: 10.1002/Cncr.31918 |
0.397 |
|
| 2019 |
Doussouki ME, Gajjar A, Chamdine O. Molecular genetics of medulloblastoma in children: diagnostic, therapeutic and prognostic implications Future Neurology. 14. DOI: 10.2217/Fnl-2018-0030 |
0.328 |
|
| 2019 |
Robinson GW, Gajjar AJ, Gauvain KM, Basu EM, Macy ME, Maese LD, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki M, Farid-Kapadia M, Meneses-Lorente G, Cardenas A, et al. Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors. Journal of Clinical Oncology. 37: 10009-10009. DOI: 10.1200/JCO.2019.37.15_SUPPL.10009 |
0.331 |
|
| 2019 |
Bihannic L, Hovestadt V, Smith K, Filbin M, Shaw M, Baumgartner A, DeWitt J, Groves A, Mayr L, Weisman H, Richman A, Shore M, Goumnerova L, Rosencrance C, Carter R, ... ... Gajjar A, et al. PDTM-32. RESOLVING MEDULLOBLASTOMA CELLULAR ARCHITECTURE BY SINGLE-CELL GENOMICS Neuro-Oncology. 21: vi194-vi194. DOI: 10.1093/Neuonc/Noz175.808 |
0.361 |
|
| 2019 |
Robinson G, Desai A, Gauvain K, Basu E, Dorris K, Maese L, Sabnis A, Foster J, Shusterman S, Yoon J, Weiss B, Abdelbaki M, Farid-Kapadia M, Meneses-Lorente G, Cardenas A, ... ... Gajjar A, et al. Pdct-13. Entrectinib In Children And Adolescents With Recurrent Or Refractory Solid Tumors Including Primary Cns Tumors Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.774 |
0.412 |
|
| 2019 |
Finlay J, Mynarek M, Dhall G, Lafay-Cousin L, Mazewski C, Ashley D, Leary S, von Bueren A, Gerber N, Cohen B, Robinson G, Russell Geyer J, Tait D, Stanek J, Gajjar A, et al. PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS Neuro-Oncology. 21: vi183-vi184. DOI: 10.1093/Neuonc/Noz175.767 |
0.391 |
|
| 2019 |
Liu APY, Kumar R, Smith K, Robinson G, Gajjar A, Northcott P. Path-18. Csf-Derived Circulating Tumor Dna Reflects Disease Course And Clonal Evolution In Medulloblastoma Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.614 |
0.314 |
|
| 2019 |
Nicolaides T, Margol A, Gajjar A, Goldman S, Gauvain K, Kilburn L, Nazemi K, Minturn J, Leary S, Whipple N, Gururangan S, Crawford J, Long-Boyle J, Wang H, Ivaturi V, et al. Ther-26. Pharmacokinetic And Updated Outcome Data From Pnoc-002: A Safety Study Of Vemurafenib, An Oral Inhibitor Of Brafv600E, In Children With Recurrent/Refractory Brafv600E Mutant Brain Tumors Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.231 |
0.399 |
|
| 2018 |
Erkek S, Johann PD, Finetti MA, Drosos Y, Chou HC, Zapatka M, Sturm D, Jones DTW, Korshunov A, Rhyzova M, Wolf S, Mallm JP, Beck K, Witt O, Kulozik AE, ... ... Gajjar A, et al. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation. Cancer Cell. PMID 30595504 DOI: 10.1016/J.Ccell.2018.11.014 |
0.349 |
|
| 2018 |
Mitchell AB, Vasilyeva A, Gajjar A, Santana VM, Stewart CF. Determining success rates of the current pharmacokinetically guided dosing approach of topotecan in pediatric oncology patients. Pediatric Blood & Cancer. e27578. PMID 30548417 DOI: 10.1002/Pbc.27578 |
0.327 |
|
| 2018 |
Heitzer AM, Ashford JM, Hastings C, Liu APY, Wu S, Bass JK, Vestal R, Hoehn M, Chiang J, Ghazwani Y, Acharya S, Boop F, Gajjar A, Merchant TE, Qaddoumi I, et al. Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life. Journal of Neuro-Oncology. PMID 30467811 DOI: 10.1007/S11060-018-03048-0 |
0.433 |
|
| 2018 |
Cherlow JM, Shaw DW, Margraf LR, Bowers DC, Huang J, Fouladi M, Onar-Thomas A, Zhou T, Pollack IF, Gajjar A, Kessel S, Cullen PL, McMullen K, Wellons JC, Merchant TE. Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase II Study XXXX. International Journal of Radiation Oncology, Biology, Physics. PMID 30419305 DOI: 10.1016/J.Ijrobp.2018.11.004 |
0.411 |
|
| 2018 |
Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Leary S, Zhou T, von Deimling A, ... ... Gajjar A, et al. Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017764720. PMID 30332335 DOI: 10.1200/Jco.2017.76.4720 |
0.473 |
|
| 2018 |
Liu APY, Harreld JH, Jacola LM, Gero M, Acharya S, Ghazwani Y, Wu S, Li X, Klimo P, Gajjar A, Chiang J, Qaddoumi I. Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis. Acta Neuropathologica Communications. 6: 101. PMID 30253793 DOI: 10.1186/S40478-018-0602-5 |
0.448 |
|
| 2018 |
Brinkman TM, Ness KK, Li Z, Huang IC, Krull KR, Gajjar A, Merchant TE, Klosky JL, Partin RE, Olsson IT, Boop F, Klimo P, Chemaitilly W, Khan RB, Srivastava D, et al. Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018779454. PMID 30091946 DOI: 10.1200/Jco.2018.77.9454 |
0.343 |
|
| 2018 |
Pajtler KW, Wen J, Sill M, Lin T, Orisme W, Tang B, Hübner JM, Ramaswamy V, Jia S, Dalton JD, Haupfear K, Rogers HA, Punchihewa C, Lee R, Easton J, ... ... Gajjar A, et al. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathologica. PMID 29909548 DOI: 10.1007/S00401-018-1877-0 |
0.308 |
|
| 2018 |
Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, ... ... Gajjar A, et al. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. The Lancet. Oncology. PMID 29778738 DOI: 10.1016/S1470-2045(18)30204-3 |
0.408 |
|
| 2018 |
Sadighi ZS, Curtis E, Zabrowksi J, Billups C, Gajjar A, Khan R, Qaddoumi I. Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatric Blood & Cancer. e27063. PMID 29741274 DOI: 10.1002/Pbc.27063 |
0.429 |
|
| 2018 |
Patel P, Wallace D, Boop FA, Vaughn B, Robinson GW, Gajjar A, Klimo P. Reoperation for Medulloblastoma Prior to Adjuvant Therapy. Neurosurgery. PMID 29660028 DOI: 10.1093/Neuros/Nyy095 |
0.312 |
|
| 2018 |
Broniscer A, Jia S, Mandrell B, Hamideh D, Huang J, Onar-Thomas A, Gajjar A, Raimondi SC, Tatevossian RG, Stewart CF. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. Pediatric Blood & Cancer. PMID 29512900 DOI: 10.1002/Pbc.27035 |
0.372 |
|
| 2018 |
Hamideh D, Hoehn ME, Harreld JH, Klimo PD, Gajjar A, Qaddoumi I. Isolated Optic Nerve Glioma in Children With and Without Neurofibromatosis: Retrospective Characterization and Analysis of Outcomes. Journal of Child Neurology. 883073818758737. PMID 29502465 DOI: 10.1177/0883073818758737 |
0.395 |
|
| 2018 |
Pinto EM, Hamideh D, Bahrami A, Orr BA, Lin T, Pounds S, Zambetti GP, Pappo AS, Gajjar A, Agnihotri S, Broniscer A. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Acta Neuropathologica. PMID 29428974 DOI: 10.1007/S00401-018-1814-2 |
0.418 |
|
| 2018 |
Nimmervoll B, Boulos N, Bianski BM, Dapper J, DeCuypere M, Shelat AA, Terranova S, Terhune HE, Gajjar A, Patel YT, Freeman BB, Onar-Thomas A, Stewart CF, Roussel MF, Guy RK, et al. Establishing A Preclinical Multidisciplinary Board for Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29301833 DOI: 10.1158/1078-0432.Ccr-17-2168 |
0.437 |
|
| 2018 |
Mueller S, Yang X, Pal S, Ermioian R, Fox E, Gajjar A, Minard C, Liu X, Prem K, Reid J, Weigel B, Haas-Kogan D. PDCT-04. PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR AZD1775 COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217) Neuro-Oncology. 20: vi201-vi201. DOI: 10.1093/Neuonc/Noy148.834 |
0.336 |
|
| 2018 |
Reddick W, Glass J, Ji Q, Conklin H, Harreld J, Robinson G, Gajjar A. RADI-20. CHANGES IN STRUCTURAL BRAIN CONNECTIVITY WITHIN THE FRONTAL LOBES DURING CRANIAL RADIOTHERAPY IN CHILDREN TREATED FOR MEDULLOBLASTOMA Neuro-Oncology. 20: i174-i174. DOI: 10.1093/Neuonc/Noy059.660 |
0.343 |
|
| 2018 |
Kumar R, Deng M, Rudneva VA, Robinson GW, Dhall G, Klesse LJ, Bowers DC, Chintagumpala M, Leary S, Orr BA, Pfister SM, Gajjar A, Jones DTW, Northcott PA. Mbrs-34. Molecular Characterization Of Recurrent Medulloblastoma Reveals An Unexpectedly High Incidence Of Secondary Malignancy Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.479 |
0.303 |
|
| 2018 |
Tinkle C, Lucas J, Srinivasan S, Tumlin P, Onar-Thomas A, Huang J, Patay Z, Ellison D, Orr B, Northcott P, Robinson G, Gajjar A, Merchant T. Mbcl-41. Treatment Failure Patterns Across Medulloblastoma Subgroups Within A Prospective Phase Ii Clinical Trial Of Risk-Adapted, Volume-Reduced Radiation Therapy And Dose-Intense Chemotherapy With Stem Cell Support Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.437 |
0.318 |
|
| 2018 |
Lafay-Cousin L, Robinson G, Rudneva V, Northcott P, Billups C, Onar-Thomas A, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Strother D, Fouladi M, Bouffet E, Gajjar A. MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP Neuro-Oncology. 20: i118-i119. DOI: 10.1093/Neuonc/Noy059.406 |
0.351 |
|
| 2018 |
Acharya S, Ellison D, Qaddoumi I, Gajjar A, Merchant T. Lgg-42. Recursive Partitioning Analysis Of Prognostic Factors For Pediatric Low-Grade Gliomas Treated With Radiation Therapy Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.383 |
0.33 |
|
| 2018 |
Carey S, Sadighi Z, Wu S, Chiang J, Ghazwani Y, Acharya S, Boop F, Gajjar A, Qaddoumi I. Lgg-30. Evaluating Pediatric Spinal Low-Grade Gliomas-A 30-Year Retrospective Analysis Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.371 |
0.301 |
|
| 2018 |
Liu A, Hastings C, Wu S, Bass JK, Heitzer A, Ashford J, Vestal R, Hoehn M, Chiang J, Ghazwani Y, Acharya S, Conklin H, Boop F, Gajjar A, Qaddoumi I. LGG-22. TREATMENT OUTCOME AND LONG-TERM HEALTH DEFICITS OF PATIENTS WITH LOW-GRADE GLIOMA DIAGNOSED DURING THE FIRST YEAR OF LIFE Neuro-Oncology. 20: i109-i109. DOI: 10.1093/Neuonc/Noy059.363 |
0.305 |
|
| 2018 |
Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, Khatua S, Boyett J, Williams-Hughes C, Souweidane M, Lu H, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, ... Gajjar A, et al. Germ-15. A Phase 2 Trial Of Response-Based Radiation Therapy For Patients With Localized Central Nervous System Germ Cell Tumors (Cns Gct): A Children’S Oncology Group (Cog) Study Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.262 |
0.389 |
|
| 2018 |
Li B, Vasiljevic A, Ho B, Norman J, Lu M, Hwang E, Hansford J, Jouvet A, Laquerriere A, Delisle M, Gururangan S, Fangusaro J, Forest F, Sumihito N, Toledano H, ... ... Gajjar A, et al. Embr-17. Pineoblastoma Segregates Into Molecular Subtypes With Distinct Clinicopathologic Features: Report From The Rare Brain Tumor Consortium Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.201 |
0.362 |
|
| 2018 |
Liu A, Orr B, Lin T, Hassall T, Bowers DC, Bouffet E, Gururangan S, Fisher P, Crawford J, Kellie SJ, Chintagumpala M, Fisher M, Bendel A, Ellison D, Robinson G, ... Gajjar A, et al. Embr-14. Reclassification Of Central Nervous System Primitive Neuroectodermal Tumor (Cns-Pnet) Into Entities Reflects Outcome: Results From The Prospective Sjyc07 And Sjmb03 Trials Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.198 |
0.366 |
|
| 2018 |
Liu A, Orr B, Lin T, Bouffet E, Gururangan S, Crawford J, Kellie SJ, Chintagumpala M, Fisher M, Bowers DC, Hassall T, Ellison D, Robinson G, Gajjar A. Embr-13. Favorable Outcomes In Children With Pineoblastoma Treated With Risk-Adapted Craniospinal Irradiation And Chemotherapy: Results And Molecular Analysis From The Sjyc07 And Sjmb03 Trials Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.197 |
0.363 |
|
| 2018 |
Hwang E, Kool M, Burger P, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Leary S, Zhou T, vonDiemling A, ... ... Gajjar A, et al. EMBR-01. MOLECULAR AND CLINICAL HETEROGENEITY IN HISTOLOGICALLY-DIAGNOSED CNS-PNET PATIENTS PROSPECTIVELY TREATED AS A SINGLE ENTITY: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL Neuro-Oncology. 20: i68-i69. DOI: 10.1093/Neuonc/Noy059.186 |
0.337 |
|
| 2018 |
Pinto E, Hamideh D, Bahrami A, Orr B, Lin T, Pounds S, Zambetti G, Pappo A, Agnihotri S, Gajjar A, Broniscer A. Atrt-03. Malignant Rhabdoid Tumors Originating Within And Outside The Central Nervous System Are Clinically And Molecularly Heterogeneous Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.002 |
0.383 |
|
| 2017 |
Robinson GW, Kaste SC, Chemaitilly W, Bowers DC, Laughton S, Smith A, Gottardo NG, Partap S, Bendel A, Wright KD, Orr BA, Warner WC, Onar-Thomas A, Gajjar A. Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor. Oncotarget. 8: 69295-69302. PMID 29050204 DOI: 10.18632/Oncotarget.20619 |
0.351 |
|
| 2017 |
Schreiber JE, Palmer SL, Conklin HM, Mabbott DJ, Swain MA, Bonner MJ, Chapieski ML, Huang L, Zhang H, Gajjar A. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. Neuro-Oncology. PMID 29016818 DOI: 10.1093/Neuonc/Nox135 |
0.361 |
|
| 2017 |
Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, ... ... Gajjar A, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 547: 311-317. PMID 28726821 DOI: 10.1038/Nature22973 |
0.339 |
|
| 2017 |
Upadhyaya SA, Ghazwani Y, Wu S, Broniscer A, Boop FA, Gajjar A, Qaddoumi I. Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study. Pediatric Blood & Cancer. PMID 28708330 DOI: 10.1002/Pbc.26717 |
0.404 |
|
| 2017 |
Hoehn ME, Calderwood J, O'Donnell T, Armstrong GT, Gajjar A. Children with dorsal midbrain syndrome as a result of pineal tumors. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus. PMID 28069468 DOI: 10.1016/J.Jaapos.2016.09.024 |
0.39 |
|
| 2017 |
Sparrow J, Zhu L, Gajjar A, Mandrell BN, Ness KK. Constraint-Induced Movement Therapy for Children With Brain Tumors. Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 29: 55-61. PMID 27984470 DOI: 10.1097/Pep.0000000000000331 |
0.392 |
|
| 2017 |
Nicolaides T, Nazemi K, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Molinaro A, Mueller S, Prados M. PDCT-19. A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002 Neuro-Oncology. 19: vi188-vi188. DOI: 10.1093/Neuonc/Nox168.761 |
0.404 |
|
| 2017 |
Hwang E, Kool M, Burger P, Capper D, Chavez L, Brabetz S, Williams-Hughes C, Billups C, Heier L, Jaju A, Michalski J, Li Y, Zhou T, Leary S, Heideman N, ... ... Gajjar A, et al. PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL Neuro-Oncology. 19: vi184-vi185. DOI: 10.1093/Neuonc/Nox168.749 |
0.41 |
|
| 2017 |
Sadighi Z, Curtis E, Zabrowski J, Onar-Thomas A, Khan R, Gajjar A, Boop F, Klimo P, Broniscer A. Ncmp-06. Neurological Outcome In Pediatric Cervicomedullary Tumors Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.557 |
0.368 |
|
| 2017 |
Smith S, Tinkle C, Bianski B, Orr B, Robinson G, Nimmervoll B, Morel V, Gilbertson R, Gajjar A, Merchant T, Roussel M. Medu-32. Advancing Preclinical Modeling Of High Risk Medulloblastoma By Performing Clinically-Relevant Radiotherapy On Patient-Derived Xenografts Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.182 |
0.318 |
|
| 2017 |
Johann PD, Erkek S, Chavez L, Finetti M, Kerl K, Zapatka M, Gajjar A, Hasselblatt M, Pfister SM, Kool M. Atrt-09. Chromatin Segmentation Analyses In Atypical Teratoid/Rhabdoid Tumors Reveal H3K27Me3-Mediated Epigenetic Silencing Of Tumor Suppressor Genes And Identify A Novel Role Of Ezh2, Associated With Active Chromatin. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.008 |
0.335 |
|
| 2017 |
Richardson C, Smith C, Merchant T, Gajjar A, Hoehn ME. Cataract incidence and severity after therapeutic radiation for brain tumors Journal of Aapos. 21. DOI: 10.1016/J.Jaapos.2017.07.087 |
0.369 |
|
| 2016 |
Broniscer A, Hwang SN, Chamdine O, Lin T, Pounds S, Onar-Thomas A, Chi L, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA. Bithalamic Gliomas May Be Molecularly Distinct From Their Unilateral High-Grade Counterparts. Brain Pathology (Zurich, Switzerland). PMID 28032389 DOI: 10.1111/Bpa.12484 |
0.424 |
|
| 2016 |
Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A. A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group. Pediatric Blood & Cancer. PMID 28000417 DOI: 10.1002/Pbc.26373 |
0.383 |
|
| 2016 |
Chemaitilly W, Armstrong GT, Gajjar A, Hudson MM. Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4315-4319. PMID 27998231 DOI: 10.1200/Jco.2016.70.1847 |
0.357 |
|
| 2016 |
Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Gajjar A, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/J.Ccell.2016.11.003 |
0.344 |
|
| 2016 |
Pajtler KW, Mack SC, Ramaswamy V, Smith CA, Witt H, Smith A, Hansford JR, von Hoff K, Wright KD, Hwang E, Frappaz D, Kanemura Y, Massimino M, Faure-Conter C, Modena P, ... ... Gajjar A, et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathologica. PMID 27858204 DOI: 10.1007/S00401-016-1643-0 |
0.338 |
|
| 2016 |
Sadighi ZS, Zabrowski J, Boop FA, Broniscer A, Gajjar A, Khan RB. Clinical Characteristics and Long-Term Outcomes of Movement Disorders in Childhood Thalamic Tumors. Pediatric Neurology. PMID 27773422 DOI: 10.1016/J.Pediatrneurol.2016.08.012 |
0.323 |
|
| 2016 |
Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, Bowers DC, Ellison D, Fangusaro J, Foreman N, Fouladi M, Gajjar A, Haas-Kogan D, Hawkins C, Ho CY, et al. Pediatric low-grade gliomas: implications of the biologic era. Neuro-Oncology. PMID 27683733 DOI: 10.1093/Neuonc/Now209 |
0.391 |
|
| 2016 |
Mandrell BN, Baker J, Levine D, Gattuso J, West N, Sykes A, Gajjar A, Broniscer A. Children with minimal chance for cure: parent proxy of the child's health-related quality of life and the effect on parental physical and mental health during treatment. Journal of Neuro-Oncology. PMID 27344555 DOI: 10.1007/S11060-016-2187-9 |
0.322 |
|
| 2016 |
Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A. Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. Cancer Medicine. PMID 27109549 DOI: 10.1002/Cam4.713 |
0.451 |
|
| 2016 |
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathologica. PMID 27040285 DOI: 10.1007/S00401-016-1569-6 |
0.372 |
|
| 2016 |
Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DT, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, ... ... Gajjar A, et al. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. PMID 26923874 DOI: 10.1016/J.Ccell.2016.02.001 |
0.399 |
|
| 2016 |
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, ... ... Gajjar A, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 164: 1060-1072. PMID 26919435 DOI: 10.1016/J.Cell.2016.01.015 |
0.431 |
|
| 2016 |
Brinkman TM, Krasin MJ, Liu W, Armstrong GT, Ojha RP, Sadighi ZS, Gupta P, Kimberg C, Srivastava D, Merchant TE, Gajjar A, Robison LL, Hudson MM, Krull KR. Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26834063 DOI: 10.1200/Jco.2015.62.2589 |
0.356 |
|
| 2016 |
Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, ... ... Gajjar A, et al. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathologica. PMID 26810070 DOI: 10.1007/S00401-016-1539-Z |
0.393 |
|
| 2016 |
Broniscer A, Chamdine O, Hwang S, Lin T, Pounds S, Onar-Thomas A, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA. Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas. Acta Neuropathologica. PMID 26744350 DOI: 10.1007/S00401-015-1532-Y |
0.428 |
|
| 2016 |
Duncan EC, Reddick WE, Glass JO, Hyun JW, Ji Q, Li Y, Gajjar A. Application of probabilistic fiber-tracking method of MR imaging to measure impact of cranial irradiation on structural brain connectivity in children treated for medulloblastoma Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9788. DOI: 10.1117/12.2217185 |
0.345 |
|
| 2016 |
Wetmore C, Turner D, Kun L, Onar-Thomas A, Huang J, Gajjar A, Baker S, Stewart C, Broniscer A. PDCT-10. FIRST IN PEDIATRICS PHASE I STUDY OF CRENOLANIB BESYLATE (CP-868,596-26) ADMINISTERED DURING AND AFTER RADIATION THERAPY (RT) IN NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND RECURRENT HIGH GRADE GLIOMA (HGG) Neuro-Oncology. 18: vi147-vi148. DOI: 10.1093/Neuonc/Now212.614 |
0.348 |
|
| 2016 |
Brinkman T, Ness K, Li Z, Krull K, Gajjar A, Merchant T, Boop F, Klimo P, Khan R, Srivastava D, Robison L, Hudson M, Armstrong G. QOS-30FUNCTIONAL INDEPENDENCE IN ADULT SURVIVORS OF PEDIATRIC CNS TUMORS: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY Neuro-Oncology. 18: iii151.4-iii151. DOI: 10.1093/Neuonc/Now081.30 |
0.363 |
|
| 2016 |
Michalski J, Vezina G, Burger P, Gajjar A, Pollack I, Merchant T, Fitzgerald T, Booth T, Tarbell N, Shieh I, Williams-Hughes C, Li Y, Billups C, Packer R, Janss A. Mb-109Preliminary Results Of Cog Acns0331: A Phase Iii Trial Of Involved Field Radiotherapy (Ifrt) And Low Dose Craniospinal Irradiation (Ld-Csi) With Chemotherapy In Average Risk Medulloblastoma: A Report From The Children'S Oncology Group Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now076.104 |
0.363 |
|
| 2016 |
Ghazwani Y, Patay Z, Sadighi ZS, Upadhyaya S, Boop F, Gajjar A, Qaddoumi I. Lg-77Brain Plasticity In Pediatric Low-Grade Gliomas. Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now075.77 |
0.383 |
|
| 2016 |
Upadhyaya S, Ghazwani Y, Wu S, Broniscer A, Ellison D, Gajjar A, Qaddoumi I. Lg-59Mortality In Children With Low-Grade Glioma: A Single-Institution Study Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now075.59 |
0.366 |
|
| 2016 |
Broniscer A, Merchant T, Nguyen R, Onar-Thomas A, Gajjar A, Patay Z. Hg-60Treatment-Related Non-Contiguous Radiological Changes In Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields And Antiangiogenic Therapy Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now073.56 |
0.345 |
|
| 2016 |
Hwang E, Billups C, Onar-Thomas A, Gururangan S, Warren K, Beaty O, Warwick A, Macdonald T, Packer R, Gajjar A, Fouladi M. Hg-41Outcomes For Patients With Recurrent Malignant Glioma Enrolled On Phase Ii Clinical Trials: An Analysis Of Contemporary Children'S Oncology Group (Cog) And Pediatric Brain Tumor Consortium (Pbtc) Trials Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now073.38 |
0.428 |
|
| 2016 |
Hwang E, Billups C, Onar-Thomas A, Warren K, Beaty O, Gururangan S, Packer R, Fouladi M, Gajjar A. Ept-06Outcomes For Patients With Recurrent Medulloblastoma Or Ependymoma Enrolled On Phase Ii Clinical Trials: An Analysis Of Contemporary Children'S Oncology Group (Cog) And Pediatric Brain Tumor Consortium (Pbtc) Trials Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now069.05 |
0.42 |
|
| 2016 |
Reddy A, Strother D, Judkins A, Krailo M, Gao Y, Douglas J, Mahajan A, Lewis V, Mazewski C, Laningham F, Pollack I, Gajjar A, Biegel J. AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP Neuro-Oncology. 18: iii2.4-iii2. DOI: 10.1093/Neuonc/Now065.08 |
0.398 |
|
| 2015 |
Bratton ML, Hoehn ME, Morris B, Merchant TE, Gajjar A, Patel R, Kerr NC. Residual Strabismus in Children Following Improvement of Cranial Nerve Palsies Affecting Ocular Ductions. The American Orthoptic Journal. 65: 87-93. PMID 26564932 DOI: 10.3368/Aoj.65.1.87 |
0.335 |
|
| 2015 |
Wright KD, Daryani VM, Turner DC, Onar-Thomas A, Boulos N, Orr BA, Gilbertson RJ, Stewart CF, Gajjar A. Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma. Neuro-Oncology. 17: 1620-7. PMID 26541630 DOI: 10.1093/Neuonc/Nov181 |
0.382 |
|
| 2015 |
Morfouace M, Nimmervoll B, Boulos N, Patel YT, Shelat A, Freeman BB, Robinson GW, Wright K, Gajjar A, Stewart CF, Gilbertson RJ, Roussel MF. Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors. Journal of Neuro-Oncology. PMID 26518542 DOI: 10.1007/S11060-015-1965-0 |
0.413 |
|
| 2015 |
Khan RB, Sadighi ZS, Zabrowski J, Gajjar A, Jeha S. Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment. Pediatric Blood & Cancer. PMID 26469881 DOI: 10.1002/Pbc.25790 |
0.4 |
|
| 2015 |
Chamdine O, Broniscer A, Wu S, Gajjar A, Qaddoumi I. Metastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital. Pediatric Blood & Cancer. PMID 26312767 DOI: 10.1002/Pbc.25731 |
0.437 |
|
| 2015 |
Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2986-98. PMID 26304884 DOI: 10.1200/Jco.2014.59.9217 |
0.437 |
|
| 2015 |
Brinkman TM, Bass JK, Li Z, Ness KK, Gajjar A, Pappo AS, Armstrong GT, Merchant TE, Srivastava DK, Robison LL, Hudson MM, Gurney JG. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study. Cancer. 121: 4053-61. PMID 26287566 DOI: 10.1002/Cncr.29604 |
0.319 |
|
| 2015 |
Green DM, Merchant TE, Billups CA, Stokes DC, Broniscer A, Bartels U, Chintagumpala M, Hassall TE, Gururangan S, McCowage GB, Heath JA, Cohn RJ, Fisher MJ, Srinivasan A, Robinson GW, ... Gajjar A, et al. Pulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation. International Journal of Radiation Oncology, Biology, Physics. 93: 47-53. PMID 26279023 DOI: 10.1200/Jco.2013.31.15_Suppl.10021 |
0.384 |
|
| 2015 |
Robinson GW, Orr BA, Wu G, Gururangan S, Lin T, Qaddoumi I, Packer RJ, Goldman S, Prados MD, Desjardins A, Chintagumpala M, Takebe N, Kaste SC, Rusch M, Allen SJ, ... ... Gajjar A, et al. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26169613 DOI: 10.1200/Jco.2014.60.1591 |
0.343 |
|
| 2015 |
Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, Ingles SA, Dunkel IJ, Hilden J, Packer RJ, Pollack IF, Gajjar A, Finlay JL. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group. Pediatric Neurology. 53: 31-46. PMID 26092413 DOI: 10.1016/J.Pediatrneurol.2015.03.019 |
0.43 |
|
| 2015 |
Zou P, Conklin HM, Scoggins MA, Li Y, Li X, Jones MM, Palmer SL, Gajjar A, Ogg RJ. Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment. Brain Imaging and Behavior. PMID 25967954 DOI: 10.1007/S11682-015-9390-8 |
0.335 |
|
| 2015 |
Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, et al. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 31: 1283-9. PMID 25930724 DOI: 10.1007/S00381-015-2725-3 |
0.433 |
|
| 2015 |
DeWire M, Fouladi M, Turner DC, Wetmore C, Hawkins C, Jacobs C, Yuan Y, Liu D, Goldman S, Fisher P, Rytting M, Bouffet E, Khakoo Y, Hwang EI, Foreman N, ... ... Gajjar A, et al. An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN). Journal of Neuro-Oncology. 123: 85-91. PMID 25859842 DOI: 10.1007/S11060-015-1764-7 |
0.404 |
|
| 2015 |
Chintagumpala M, Eckel SP, Krailo M, Morris M, Adesina A, Packer R, Lau C, Gajjar A. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†. Neuro-Oncology. 17: 1132-8. PMID 25854526 DOI: 10.1093/Neuonc/Nov057 |
0.475 |
|
| 2015 |
Arnautovic A, Billups C, Broniscer A, Gajjar A, Boop F, Qaddoumi I. Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 31: 1067-77. PMID 25742877 DOI: 10.1007/S00381-015-2670-1 |
0.386 |
|
| 2015 |
Wetmore C, Boyett J, Li S, Lin T, Bendel A, Gajjar A, Orr BA. Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children. Neuro-Oncology. 17: 882-8. PMID 25688119 DOI: 10.1093/Neuonc/Nov017 |
0.473 |
|
| 2015 |
Xu H, Robinson GW, Huang J, Lim JY, Zhang H, Bass JK, Broniscer A, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Fisher M, Cohn R, Yamashita T, Teitz T, ... ... Gajjar A, et al. Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nature Genetics. 47: 263-6. PMID 25665007 DOI: 10.1038/Ng.3217 |
0.367 |
|
| 2015 |
Wright KD, Sabin ND, Cheuk D, McNall-Knapp R, Shurtleff SA, Gajjar A, Broniscer A. Incidental diagnosis of diffuse intrinsic pontine glioma in children. Pediatric Blood & Cancer. 62: 1081-3. PMID 25598012 DOI: 10.1002/Pbc.25408 |
0.377 |
|
| 2015 |
Tsui K, Gajjar A, Li C, Srivastava D, Broniscer A, Wetmore C, Kun LE, Merchant TE, Ellison DW, Orr BA, Boop FA, Klimo P, Ross J, Robison LL, Armstrong GT. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro-Oncology. 17: 448-56. PMID 25395462 DOI: 10.1093/Neuonc/Nou279 |
0.394 |
|
| 2015 |
Wright KD, Panetta JC, Onar-Thomas A, Reddick WE, Patay Z, Qaddoumi I, Broniscer A, Robinson G, Boop FA, Klimo P, Ward D, Gajjar A, Stewart CF. Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemotherapy and Pharmacology. 75: 27-35. PMID 25342291 DOI: 10.1007/S00280-014-2614-6 |
0.427 |
|
| 2015 |
Morfouace M, Patel Y, Shelat A, Kawauchi D, Robinson GW, Guy K, Gilbertson RJ, Stewart C, Gajjar A, Roussel MF. Abstract IA21: Pediatric medulloblastoma: Drug screens and preclinical studies Brain. 75. DOI: 10.1158/1538-7445.Brain15-Ia21 |
0.333 |
|
| 2015 |
Daryani VM, Owens TS, Harstead KE, Patel YT, Turner DC, Throm SL, Panetta JC, Gajjar A, Stewart CF. Abstract 4526: Age dependent disposition of cyclophosphamide (CTX) and metabolites in infants ≤ 1 year old with brain tumors Cancer Research. 75: 4526-4526. DOI: 10.1158/1538-7445.Am2015-4526 |
0.344 |
|
| 2015 |
Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Korshunov A, Marina R, Jones DTW, Northcott PA, Frühwald M, Gajjar A, Hasselblatt M, Pfister SM, Kool M. Ptps-11Atypical Teratoid/Rhabdoid Tumour Is An Epigenetically Heterogeneous Disease Characterized By Subgroup Specific Super-Enhancers Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov228.11 |
0.389 |
|
| 2015 |
Sadighi Z, Khan R, Zabrowski J, Gajjar A, Jeha S. Epid-24Imaging Patterns And Outcome Of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov213.24 |
0.324 |
|
| 2015 |
Johann P, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Korshunov A, Rhyzova M, Jones DTW, Northcott PA, Frühwald MC, Hasselblatt M, Gajjar A, Pfister SM, Kool M. At-03Atypical Teratoid/Rhabdoid Tumour Is A Genetically Homogeneous But Epigenetically Heterogeneous Disease That Is Defined By Subgroup Specific Super-Enhancers Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.3 |
0.344 |
|
| 2015 |
Hoffman LM, Geller J, Leach J, Boue D, Drissi R, Chen L, Krailo M, Panandiker AP, Chow L, Haas-Kogan D, Jogal S, Nelson M, Jakacki R, Kieran M, Cohen K, ... ... Gajjar A, et al. Tr-14A Feasibility And Randomized Phase Ii Study Of Vorinostat, Bevacizumab, Or Temozolomide During Radiation Followed By Maintenance Chemotherapy In Newly-Diagnosed Pediatric High-Grade Glioma: Children'S Oncology Group Study Acns0822 Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.159 |
0.367 |
|
| 2014 |
Chamdine O, Gajjar A. Molecular characteristics of pediatric high-grade gliomas. Cns Oncology. 3: 433-43. PMID 25438814 DOI: 10.2217/Cns.14.43 |
0.395 |
|
| 2014 |
Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ. Molecular insights into pediatric brain tumors have the potential to transform therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5630-40. PMID 25398846 DOI: 10.1158/1078-0432.Ccr-14-0833 |
0.468 |
|
| 2014 |
DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin MJ, Boyett JM, Wright KD, Wetmore C, Broniscer A, Gajjar A. Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy. Pediatric Blood & Cancer. PMID 25327609 DOI: 10.1002/Pbc.25274 |
0.4 |
|
| 2014 |
Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma. International Journal of Radiation Oncology, Biology, Physics. 90: 554-61. PMID 25160611 DOI: 10.1016/J.Ijrobp.2014.06.058 |
0.356 |
|
| 2014 |
Wetmore C, Herington D, Lin T, Onar-Thomas A, Gajjar A, Merchant TE. Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? Cancer. 120: 3731-7. PMID 25080363 DOI: 10.1002/Cncr.28907 |
0.365 |
|
| 2014 |
Northcott PA, Lee C, Zichner T, Stütz AM, Erkek S, Kawauchi D, Shih DJ, Hovestadt V, Zapatka M, Sturm D, Jones DT, Kool M, Remke M, Cavalli FM, Zuyderduyn S, ... ... Gajjar A, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 511: 428-34. PMID 25043047 DOI: 10.1038/Nature13379 |
0.312 |
|
| 2014 |
Duggin K, Tickle K, Norman G, Yang J, Wang C, Cross SJ, Gajjar A, Mandrell B. Aprepitant reduces chemotherapy-induced vomiting in children and young adults with brain tumors. Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses. 31: 277-83. PMID 24972782 DOI: 10.1177/1043454214531090 |
0.408 |
|
| 2014 |
Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Gajjar A, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/S00401-014-1291-1 |
0.421 |
|
| 2014 |
Robinson GW, Orr BA, Gajjar A. Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. Bmc Cancer. 14: 258. PMID 24725538 DOI: 10.1186/1471-2407-14-258 |
0.409 |
|
| 2014 |
Ledet D, Delos Santos NM, Khan R, Gajjar A, Broniscer A. Central neurogenic hyperventilation and renal tubular acidosis in children with pontine gliomas. Neurology. 82: 1099-100. PMID 24532275 DOI: 10.1212/Wnl.0000000000000252 |
0.363 |
|
| 2014 |
Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, Zhang H, Swain M, Chapieski ML, Bonner MJ, Mabbott DJ, Knight SJ, Armstrong CL, Boyle R, Gajjar A. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro-Oncology. 16: 1129-36. PMID 24497405 DOI: 10.1093/Neuonc/Nou006 |
0.32 |
|
| 2014 |
Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Gajjar A, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/Jco.2013.50.9539 |
0.334 |
|
| 2014 |
Pai Panandiker AS, Wong JK, Nedelka MA, Wu S, Gajjar A, Broniscer A. Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma. Pediatric Blood & Cancer. 61: 1180-3. PMID 24482196 DOI: 10.1002/Pbc.24971 |
0.388 |
|
| 2014 |
Gurney JG, Bass JK, Onar-Thomas A, Huang J, Chintagumpala M, Bouffet E, Hassall T, Gururangan S, Heath JA, Kellie S, Cohn R, Fisher MJ, Panandiker AP, Merchant TE, Srinivasan A, ... ... Gajjar A, et al. Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma. Neuro-Oncology. 16: 848-55. PMID 24414535 DOI: 10.1093/Neuonc/Not241 |
0.384 |
|
| 2014 |
Palmer SL, Leigh L, Ellison SC, Onar-Thomas A, Wu S, Qaddoumi I, Armstrong GT, Wright K, Wetmore C, Broniscer A, Gajjar A. Feasibility and efficacy of a computer-based intervention aimed at preventing reading decoding deficits among children undergoing active treatment for medulloblastoma: results of a randomized trial. Journal of Pediatric Psychology. 39: 450-8. PMID 24369366 DOI: 10.1093/Jpepsy/Jst095 |
0.327 |
|
| 2014 |
Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro-Oncology. 16: 457-65. PMID 24335695 DOI: 10.1093/Neuonc/Not163 |
0.453 |
|
| 2014 |
Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, et al. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. Neuro-Oncology. 16: 310-7. PMID 24311632 DOI: 10.1093/Neuonc/Not154 |
0.44 |
|
| 2014 |
Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, ... ... Gajjar A, et al. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathologica. 127: 189-201. PMID 24264598 DOI: 10.1007/S00401-013-1213-7 |
0.352 |
|
| 2014 |
Broniscer A, Tatevossian RG, Sabin ND, Klimo P, Dalton J, Lee R, Gajjar A, Ellison DW. Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. Neuropathology and Applied Neurobiology. 40: 327-36. PMID 24127995 DOI: 10.1111/Nan.12093 |
0.367 |
|
| 2014 |
Nageswara Rao AA, Wallace DJ, Billups C, Boyett JM, Gajjar A, Packer RJ. Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group. Pediatric Blood & Cancer. 61: 102-6. PMID 23956184 DOI: 10.1002/Pbc.24670 |
0.394 |
|
| 2014 |
Wetmore C, Broniscer A, Turner D, Wright KD, Pai-Panandiker A, Kun LE, Ramachandran A, Onar-Thomas A, Huang J, Gajjar AJ, Baker S, Stewart CF. First-in-pediatrics phase I study of crenolanib besylate (CP-868,596-26) administered during and after radiation therapy (RT) in newly diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent high-grade glioma (HGG). Journal of Clinical Oncology. 32: 10064-10064. DOI: 10.1200/Jco.2014.32.15_Suppl.10064 |
0.338 |
|
| 2014 |
Walsh M, Wu G, Edmonson M, Gruber TA, Easton J, Yergeau D, Vadodaria B, Ma X, Chen X, McGee R, Odom C, Shurtleff SA, Parker M, Rusch M, Hedlund E, ... ... Gajjar A, et al. Incidence of Germline Mutations in Cancer-Predisposition Genes in Children with Hematologic Malignancies: a Report from the Pediatric Cancer Genome Project Blood. 124: 127-127. DOI: 10.1182/Blood.V124.21.127.127 |
0.333 |
|
| 2014 |
Diaz AK, Wu G, Paugh BS, Li Y, Zhu X, Rankin S, Qu C, Chen X, Zhang J, Easton J, Edmonson M, Lu C, Nagahawatte P, Hedlund E, Rusch M, ... ... Gajjar A, et al. Abstract PR03: The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Pr03 |
0.367 |
|
| 2014 |
Sadighi Z, Zabrowski J, Broniscer A, Gajjar A, Khan R. Ed-27Clinical Characteristics And Long-Term Outcome In Movement Disorder In Childhood Thalamic Tumors Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou253.27 |
0.418 |
|
| 2014 |
Armstrong TS, Aldape K, Gajjar A, Haynes C, Hirakawa D, Gilbertson R, Gilbert MR. O8.10 * A MODEL FOR RESEARCH INITIATIVES FOR RARE CANCERS: THE COLLABORATIVE EPENDYMOMA RESEARCH NETWORK (CERN) Neuro-Oncology. 16: ii20-ii20. DOI: 10.1093/Neuonc/Nou174.71 |
0.338 |
|
| 2014 |
Wright K, Turner D, Haddock K, Jacus M, Harstead K, Throm S, Daryani V, Robinson G, Armstrong G, Onar-Thomas A, Stewart C, Gajjar A. 416 Results of phase I study of bolus 5-fluorouracil in children and young adults with recurrent ependymoma European Journal of Cancer. 50: 133. DOI: 10.1016/S0959-8049(14)70542-8 |
0.328 |
|
| 2014 |
Boulos N, Dapper J, Patel Y, DeCuypere M, Bianski B, Mohankumar K, Jacus M, III BF, Wright K, Gajjar A, Shelat A, Stewart C, Guy R, Gilbertson R. 193 The identification of new therapies for ependymoma subgroups European Journal of Cancer. 50: 63. DOI: 10.1016/S0959-8049(14)70319-3 |
0.362 |
|
| 2013 |
Hatton BA, Ellison DW, Gajjar A, Kool M, Fero M, Olson JM. Prognostic value and functional consequences of cell cycle inhibitor p27Kip1 loss in medulloblastoma. Biomarker Research. 1: 14. PMID 24252239 DOI: 10.1186/2050-7771-1-14 |
0.409 |
|
| 2013 |
Fangusaro J, Gururangan S, Poussaint TY, McLendon RE, Onar-Thomas A, Warren KE, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, et al. Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer. 119: 4180-7. PMID 24104527 DOI: 10.1002/Cncr.28343 |
0.48 |
|
| 2013 |
Gajjar A, Stewart CF, Ellison DW, Kaste S, Kun LE, Packer RJ, Goldman S, Chintagumpala M, Wallace D, Takebe N, Boyett JM, Gilbertson RJ, Curran T. Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6305-12. PMID 24077351 DOI: 10.1158/1078-0432.Ccr-13-1425 |
0.427 |
|
| 2013 |
MacDonald TJ, Vezina G, Stewart CF, Turner D, Pierson CR, Chen L, Pollack IF, Gajjar A, Kieran MW. Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group. Neuro-Oncology. 15: 1438-44. PMID 24014381 DOI: 10.1093/Neuonc/Not058 |
0.45 |
|
| 2013 |
Fouladi M, Stewart CF, Blaney SM, Onar-Thomas A, Schaiquevich P, Packer RJ, Goldman S, Geyer JR, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. Journal of Neuro-Oncology. 114: 173-9. PMID 23836190 DOI: 10.1007/S11060-013-1166-7 |
0.455 |
|
| 2013 |
Jackson S, Patay Z, Howarth R, Pai Panandiker AS, Onar-Thomas A, Gajjar A, Broniscer A. Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 114: 339-44. PMID 23813229 DOI: 10.1007/S11060-013-1189-0 |
0.455 |
|
| 2013 |
Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, ... ... Gajjar A, et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nature Genetics. 45: 602-12. PMID 23583981 DOI: 10.1038/Ng.2611 |
0.394 |
|
| 2013 |
Broniscer A, Baker SD, Wetmore C, Pai Panandiker AS, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF. Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3050-8. PMID 23536435 DOI: 10.1158/1078-0432.Ccr-13-0306 |
0.355 |
|
| 2013 |
Kaste SC, Kaufman RA, Gajjar A, Broniscer A. Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors. Pediatric Blood & Cancer. 60: 1552-6. PMID 23526749 DOI: 10.1002/Pbc.24536 |
0.393 |
|
| 2013 |
Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, et al. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathology (Zurich, Switzerland). 23: 584-94. PMID 23452038 DOI: 10.1111/Bpa.12050 |
0.35 |
|
| 2013 |
Ris MD, Walsh K, Wallace D, Armstrong FD, Holmes E, Gajjar A, Zhou T, Packer RJ. Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961. Pediatric Blood & Cancer. 60: 1350-7. PMID 23444345 DOI: 10.1002/Pbc.24496 |
0.425 |
|
| 2013 |
Klimo P, Pai Panandiker AS, Thompson CJ, Boop FA, Qaddoumi I, Gajjar A, Armstrong GT, Ellison DW, Kun LE, Ogg RJ, Sanford RA. Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience. Journal of Neurosurgery. Pediatrics. 11: 274-81. PMID 23289916 DOI: 10.3171/2012.11.Peds12317 |
0.486 |
|
| 2013 |
Gajjar A, Packer RJ, Foreman NK, Cohen K, Haas-Kogan D, Merchant TE. Children's Oncology Group's 2013 blueprint for research: central nervous system tumors. Pediatric Blood & Cancer. 60: 1022-6. PMID 23255213 DOI: 10.1002/Pbc.24427 |
0.48 |
|
| 2013 |
Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. Neuro-Oncology. 15: 97-103. PMID 23099653 DOI: 10.1093/Neuonc/Nos267 |
0.463 |
|
| 2013 |
Sabin ND, Merchant TE, Harreld JH, Patay Z, Klimo P, Qaddoumi I, Armstrong GT, Wright K, Gray J, Indelicato DJ, Gajjar A. Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy. Ajnr. American Journal of Neuroradiology. 34: 446-50. PMID 22821924 DOI: 10.3174/Ajnr.A3219 |
0.412 |
|
| 2013 |
DeWire MD, Beltran C, Boop FA, Helton KJ, Ellison DW, McKinnon PJ, Gajjar A, Pai Panandiker AS. Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: e12-4. PMID 22689803 DOI: 10.1200/Jco.2011.40.1430 |
0.386 |
|
| 2013 |
Nolan VG, Gapstur R, Gross CR, Desain LA, Neglia JP, Gajjar A, Klosky JL, Merchant TE, Stovall M, Ness KK. Sleep disturbances in adult survivors of childhood brain tumors. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 781-9. PMID 22669471 DOI: 10.1007/S11136-012-0208-5 |
0.301 |
|
| 2013 |
Turner DC, Freeman BB, Jacus MO, Morfouace M, Throm SL, Vuppala PK, Roussel M, Gajjar A, Stewart CF. Abstract 2749: Gemcitabine (GEM), a drug with clinical activity against pediatric solid tumors, demonstrates satisfactory CNS penetration in a preclinical murine medulloblastoma (MB) model. Cancer Research. 73: 2749-2749. DOI: 10.1158/1538-7445.Am2013-2749 |
0.357 |
|
| 2012 |
Donahue B, Marymont MA, Kessel S, Iandoli MK, Fitzgerald T, Holmes E, Kocak M, Boyett JM, Gajjar A, Packer RJ. Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials. Frontiers in Oncology. 2: 185. PMID 23316474 DOI: 10.3389/Fonc.2012.00185 |
0.358 |
|
| 2012 |
Brinkman TM, Palmer SL, Chen S, Zhang H, Evankovich K, Swain MA, Bonner MJ, Janzen L, Knight S, Armstrong CL, Boyle R, Gajjar A. Parent-reported social outcomes after treatment for pediatric embryonal tumors: a prospective longitudinal study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4134-40. PMID 23071220 DOI: 10.1200/Jco.2011.40.6702 |
0.369 |
|
| 2012 |
Gururangan S, Fangusaro J, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Gajjar A, Goldman S, Friedman HS, Packer RJ, Boyett JM, Kun LE, McLendon R. Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study. Neuro-Oncology. 14: 1404-12. PMID 23019233 DOI: 10.1093/Neuonc/Nos213 |
0.398 |
|
| 2012 |
Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Frontiers in Oncology. 2: 114. PMID 22988546 DOI: 10.3389/Fonc.2012.00114 |
0.428 |
|
| 2012 |
Palmer SL, Glass JO, Li Y, Ogg R, Qaddoumi I, Armstrong GT, Wright K, Wetmore C, Broniscer A, Gajjar A, Reddick WE. White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumor. Neuro-Oncology. 14: 1185-93. PMID 22898373 DOI: 10.1093/Neuonc/Nos154 |
0.351 |
|
| 2012 |
Wright KD, Gajjar A. Current treatment options for pediatric and adult patients with ependymoma. Current Treatment Options in Oncology. 13: 465-77. PMID 22798016 DOI: 10.1007/S11864-012-0205-5 |
0.446 |
|
| 2012 |
Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, et al. Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). Journal of Neuro-Oncology. 109: 565-71. PMID 22790443 DOI: 10.1007/S11060-012-0929-X |
0.447 |
|
| 2012 |
Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. International Journal of Radiation Oncology, Biology, Physics. 83: e655-60. PMID 22768993 DOI: 10.1016/J.Ijrobp.2012.01.061 |
0.398 |
|
| 2012 |
Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TS, Kim SK, Ra YS, Fangusaro J, Korshunov A, Toledano H, Nakamura H, Hayden JT, Chan J, Lafay-Cousin L, ... ... Gajjar A, et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. The Lancet. Oncology. 13: 838-48. PMID 22691720 DOI: 10.1016/S1470-2045(12)70257-7 |
0.317 |
|
| 2012 |
Qaddoumi I, Sane M, Li S, Kocak M, Pai-Panandiker A, Harreld J, Klimo P, Wright K, Broniscer A, Gajjar A. Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 28: 1017-24. PMID 22547227 DOI: 10.1007/S00381-012-1762-4 |
0.366 |
|
| 2012 |
Godfraind C, Kaczmarska JM, Kocak M, Dalton J, Wright KD, Sanford RA, Boop FA, Gajjar A, Merchant TE, Ellison DW. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathologica. 124: 247-57. PMID 22526017 DOI: 10.1007/s00401-012-0981-9 |
0.319 |
|
| 2012 |
Wright KD, von der Embse K, Coleman J, Patay Z, Ellison DW, Gajjar A. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases. Pediatric Blood & Cancer. 59: 561-4. PMID 22147345 DOI: 10.1002/Pbc.24002 |
0.386 |
|
| 2012 |
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 123: 465-72. PMID 22134537 DOI: 10.1007/S00401-011-0922-Z |
0.32 |
|
| 2012 |
Hua C, Merchant TE, Gajjar A, Broniscer A, Zhang Y, Li Y, Glenn GR, Kun LE, Ogg RJ. Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imaging. International Journal of Radiation Oncology, Biology, Physics. 82: 2047-54. PMID 21664060 DOI: 10.1016/J.Ijrobp.2011.03.057 |
0.409 |
|
| 2012 |
Pai Panandiker AS, Merchant TE, Beltran C, Wu S, Sharma S, Boop FA, Jenkins JJ, Helton KJ, Wright KD, Broniscer A, Kun LE, Gajjar A. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. International Journal of Radiation Oncology, Biology, Physics. 82: 1756-63. PMID 21601374 DOI: 10.1016/J.Ijrobp.2011.02.059 |
0.453 |
|
| 2012 |
Wetmore C, Broniscer A, Wright KD, Pai-Panandiker A, Patay Z, Onar-Thomas A, Ramachandran A, Gajjar A, Turner DC, Stewart CS. 346 First in Pediatrics Phase I Study of Crenolanib Besylate (CP-868, 596–26) Administered During and After Radiation Therapy (RT) in Newly-diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) and Recurrent High Grade Glioma, Including DIPG (HGG) European Journal of Cancer. 48: 105-106. DOI: 10.1016/S0959-8049(12)72144-5 |
0.35 |
|
| 2011 |
Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, ... ... Gajjar A, et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell. 20: 384-99. PMID 21907928 DOI: 10.1016/J.Ccr.2011.08.013 |
0.325 |
|
| 2011 |
Van Poppel M, Klimo P, Dewire M, Sanford RA, Boop F, Broniscer A, Wright K, Gajjar AJ. Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experience. Journal of Neurosurgery. Pediatrics. 8: 251-6. PMID 21882915 DOI: 10.3171/2011.6.PEDS11158 |
0.312 |
|
| 2011 |
Zou P, Helton KJ, Smeltzer M, Li CS, Conklin HM, Gajjar A, Wang WC, Ware RE, Ogg RJ. Hemodynamic responses to visual stimulation in children with sickle cell anemia. Brain Imaging and Behavior. 5: 295-306. PMID 21881848 DOI: 10.1007/S11682-011-9133-4 |
0.309 |
|
| 2011 |
Fouladi M, Stewart CF, Olson J, Wagner LM, Onar-Thomas A, Kocak M, Packer RJ, Goldman S, Gururangan S, Gajjar A, Demuth T, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3529-34. PMID 21825264 DOI: 10.1200/Jco.2011.35.7806 |
0.424 |
|
| 2011 |
Qaddoumi I, Carey SS, Conklin H, Jenkins J, Sabin N, Boop F, Pai-Panandiker A, Baker J, Wright K, Broniscer A, Gajjar A. Characterization, treatment, and outcome of intracranial neoplasms in the first 120 days of life. Journal of Child Neurology. 26: 988-94. PMID 21532007 DOI: 10.1177/0883073811401398 |
0.434 |
|
| 2011 |
Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB. Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro-Oncology. 13: 223-34. PMID 21177781 DOI: 10.1093/Neuonc/Noq178 |
0.34 |
|
| 2011 |
Atkinson JM, Shelat AA, Kranenburg TA, Carcaboso AM, Arnold A, Wright KD, Johnson RA, Poppleton H, Mohankumar KM, Gibson P, Phoenix TN, Zhu L, Tong Y, Eden C, Gajjar A, et al. Abstract 4759: Integrated in vitro and in vivo screening of tumor and normal neural stem cells identifies potential new treatments of ependymoma Cancer Research. 71: 4759-4759. DOI: 10.1158/1538-7445.Am2011-4759 |
0.336 |
|
| 2011 |
Gibson P, Tong Y, Robinson G, Poppleton H, Thompson MC, Currle DS, Eden C, Hogg TL, Finkelstein D, Pounds S, Patay Z, Scoggins M, Pei Y, Ogg R, Lee Y, ... ... Gajjar A, et al. Abstract 3448: Subtypes of medulloblastoma have distinct developmental origins Cancer Research. 71: 3448-3448. DOI: 10.1158/1538-7445.Am2011-3448 |
0.388 |
|
| 2011 |
Kawauchi D, Robinson G, Uziel T, Rehg J, Zindy F, Qu C, Gajjar A, Gilbertson RJ, Roussel MF. Abstract 3444: Enforced expression of MycN and C-Myc induces different medulloblastoma subtypes Cancer Research. 71: 3444-3444. DOI: 10.1158/1538-7445.Am2011-3444 |
0.336 |
|
| 2011 |
Merchant T, Hua C, Bass J, Wu S, Xiong X, Gajjar A. The Impact of Ototoxic Chemotherapy on Hearing Loss after Radiation Therapy in Children with Brain Tumors International Journal of Radiation Oncology*Biology*Physics. 81: S113-S114. DOI: 10.1016/J.IJROBP.2011.06.231 |
0.301 |
|
| 2010 |
Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, Finkelstein D, Pounds S, Weiss A, Patay Z, Scoggins M, ... ... Gajjar A, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature. 468: 1095-9. PMID 21150899 DOI: 10.1038/Nature09587 |
0.309 |
|
| 2010 |
Tatevossian RG, Tang B, Dalton J, Forshew T, Lawson AR, Ma J, Neale G, Shurtleff SA, Bailey S, Gajjar A, Baker SJ, Sheer D, Ellison DW. MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas. Acta Neuropathologica. 120: 731-43. PMID 21046410 DOI: 10.1007/S00401-010-0763-1 |
0.356 |
|
| 2010 |
Fouladi M, Stewart CF, Blaney SM, Onar-Thomas A, Schaiquevich P, Packer RJ, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4221-7. PMID 20713864 DOI: 10.1200/Jco.2010.28.4687 |
0.404 |
|
| 2010 |
Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, Cohn R, Fisher MJ, Morris EB, Broniscer A, Gajjar A. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro-Oncology. 12: 1311-7. PMID 20713408 DOI: 10.1093/Neuonc/Noq094 |
0.4 |
|
| 2010 |
Qaddoumi I, Ellison DW, Morris EB, Broniscer A, Boop F, Merchant T, Palmer SL, Gajjar A. Dysembryoplastic neuroepithelial tumors and cognitive outcome: cure at a price? Cancer. 116: 5461-9. PMID 20672357 DOI: 10.1002/Cncr.25528 |
0.449 |
|
| 2010 |
Wright KD, Qaddoumi I, Patay Z, Gajjar A, Wilson MW, Rodriguez-Galindo C. Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy. Pediatric Blood & Cancer. 55: 570-2. PMID 20658634 DOI: 10.1002/Pbc.22545 |
0.425 |
|
| 2010 |
Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer JR, Morris EB, Gajjar A. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer. 116: 4632-7. PMID 20589749 DOI: 10.1002/Cncr.25405 |
0.331 |
|
| 2010 |
Ness KK, Morris EB, Nolan VG, Howell CR, Gilchrist LS, Stovall M, Cox CL, Klosky JL, Gajjar A, Neglia JP. Physical performance limitations among adult survivors of childhood brain tumors. Cancer. 116: 3034-44. PMID 20564409 DOI: 10.1002/Cncr.25051 |
0.311 |
|
| 2010 |
Palmer SL, Reddick WE, Glass JO, Ogg R, Patay Z, Wallace D, Gajjar A. Regional white matter anisotropy and reading ability in patients treated for pediatric embryonal tumors. Brain Imaging and Behavior. 4: 132-40. PMID 20502994 DOI: 10.1007/S11682-010-9092-1 |
0.373 |
|
| 2010 |
Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3061-8. PMID 20479398 DOI: 10.1200/Jco.2009.26.7252 |
0.316 |
|
| 2010 |
Gajjar A, Pizer B. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors Pediatric Blood and Cancer. 54: 649-651. PMID 20146223 DOI: 10.1002/Pbc.22378 |
0.426 |
|
| 2010 |
McKibbin T, Panetta JC, Fouladi M, Gajjar A, Bai F, Okcu MF, Stewart CF. Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma Clinical Cancer Research. 16: 1049-1057. PMID 20103669 DOI: 10.1158/1078-0432.Ccr-09-1997 |
0.319 |
|
| 2010 |
McKibbin T, Tagen M, Panetta JC, Ward D, Gajjar AJ, Wright KD, Broniscer A, Stewart CF. Clinical pharmacokinetics (PK) and safety of high-dose (HD) methotrexate (MTX) during induction therapy of pediatric patients younger than 3 years of age with primary brain tumors. Journal of Clinical Oncology. 28: 9580-9580. DOI: 10.1200/JCO.2010.28.15_SUPPL.9580 |
0.309 |
|
| 2010 |
Fouladi M, Olson J, Stewart CF, Kocak M, Gajjar AJ, Demuth T, Goldman S, Kun LE, Boyett JM, Gilbertson RJ. A phase I trial of MK-0752 in children with recurrent or refractory CNS malignancies: A Pediatric Brain Tumor Consortium study. Journal of Clinical Oncology. 28: 9502-9502. DOI: 10.1200/Jco.2010.28.15_Suppl.9502 |
0.311 |
|
| 2010 |
Tagen M, Panetta JC, Gajjar A, Stewart CF. Abstract 2758: Population pharmacokinetics of cyclophosphamide in infants and young children Cancer Research. 70: 2758-2758. DOI: 10.1158/1538-7445.Am10-2758 |
0.365 |
|
| 2010 |
Murphy E, Merchant T, Wu S, Xiong X, Gajjar A. Necrosis after Craniospinal Irradiation: Results from a Prospective Series of Children with CNS Embryonal Tumors International Journal of Radiation Oncology*Biology*Physics. 78: S19. DOI: 10.1016/J.IJROBP.2010.07.085 |
0.317 |
|
| 2010 |
Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Peter Collins V, Van Meter T, Picard D, Zhou L, Boutros P, Modena P, Liang ML, Scherer SW, Bouffet E, ... ... Gajjar A, et al. Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors (DOI:10.1016/j.ccr.2009.10.025) Cancer Cell. 17: 413. DOI: 10.1016/J.Ccr.2010.03.016 |
0.36 |
|
| 2010 |
Gajjar A, Clifford SC. Embryonal Tumors Pediatric Hematology and Oncology: Scientifi C Principles and Clinical Practice. 34-51. DOI: 10.1002/9781444315134.Ch4 |
0.359 |
|
| 2009 |
Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: A review of 6212 cases from the surveillance, epidemiology, and end results database Cancer. 115: 5761-5770. PMID 19813274 DOI: 10.1002/Cncr.24663 |
0.445 |
|
| 2009 |
Dewire MD, Ellison DW, Patay Z, McKinnon PJ, Sanders RP, Gajjar A. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor. Pediatric Blood & Cancer. 53: 1140-2. PMID 19530235 DOI: 10.1002/Pbc.22139 |
0.401 |
|
| 2009 |
Fouladi M, Gururangan S, Moghrabi A, Phillips P, Gronewold L, Wallace D, Sanford RA, Gajjar A, Kun LE, Heideman R. Carboplatin-based primary chemotherapy for infants and young children with CNS tumors Cancer. 115: 3243-3253. PMID 19484793 DOI: 10.1002/Cncr.24362 |
0.446 |
|
| 2009 |
Armstrong GT, Whitton JA, Gajjar A, Kun LE, Chow EJ, Stovall M, Leisenring W, Robison LL, Sklar CA. Abnormal timing of Menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study Cancer. 115: 2562-2570. PMID 19309737 DOI: 10.1002/Cncr.24294 |
0.42 |
|
| 2009 |
Wright KD, Gajjar A. New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 25: 1275-82. PMID 19212772 DOI: 10.1007/S00381-009-0809-7 |
0.326 |
|
| 2009 |
Broniscer A, Baker SJ, Stewart CF, Merchant TE, Laningham FH, Schaiquevich P, Kocak M, Morris EB, Endersby R, Ellison DW, Gajjar A. Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 701-7. PMID 19147777 DOI: 10.1158/1078-0432.Ccr-08-1923 |
0.377 |
|
| 2009 |
Chintagumpala M, Hassall T, Palmer S, Ashley D, Wallace D, Kasow K, Merchant TE, Krasin MJ, Dauser R, Boop F, Krance R, Woo S, Cheuk R, Lau C, Gilbertson R, ... Gajjar A, et al. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET Neuro-Oncology. 11: 33-40. PMID 18796696 DOI: 10.1215/15228517-2008-079 |
0.394 |
|
| 2009 |
Pai Panandiker A, Beltran C, Naik M, Sharma S, Gajjar A, Merchant T. Impact of Radiotherapy on Overall Survival in Children with Atypical Teratoid Rhabdoid Tumors International Journal of Radiation Oncology*Biology*Physics. 75: S38-S39. DOI: 10.1016/J.IJROBP.2009.07.109 |
0.317 |
|
| 2008 |
Gottardo NG, Gajjar A. Chemotherapy for malignant brain tumors of childhood Journal of Child Neurology. 23: 1149-1159. PMID 18952581 DOI: 10.1177/0883073808321765 |
0.459 |
|
| 2008 |
Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant TE, Gajjar A. M1 Medulloblastoma: high risk at any age. Journal of Neuro-Oncology. 90: 351-5. PMID 18704266 DOI: 10.1007/S11060-008-9671-9 |
0.377 |
|
| 2008 |
Broniscer A, Laningham FH, Sanders RP, Kun LE, Ellison DW, Gajjar A. Young age may predict a better outcome for children with diffuse pontine glioma. Cancer. 113: 566-72. PMID 18484645 DOI: 10.1002/Cncr.23584 |
0.448 |
|
| 2008 |
Helton KJ, Weeks JK, Phillips NS, Zou P, Kun LE, Khan RB, Gajjar A, Fouladi M, Broniscer A, Boop F, Li CS, Ogg RJ. Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. Journal of Neurosurgery. Pediatrics. 1: 270-6. PMID 18377301 DOI: 10.3171/Ped/2008/1/4/270 |
0.332 |
|
| 2008 |
Hijiya N, Stewart CF, Zhou Y, Campana D, Coustan-Smith E, Rivera GK, Relling MV, Pui CH, Gajjar A. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse. Cancer. 112: 1983-91. PMID 18318429 DOI: 10.1002/Cncr.23395 |
0.309 |
|
| 2008 |
Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial Journal of Clinical Oncology. 26: 1112-1118. PMID 18309946 DOI: 10.1200/Jco.2008.13.5293 |
0.37 |
|
| 2008 |
Gajjar A. High-dose chemotherapy for recurrent medulloblastoma: Time for a reappraisal Cancer. 112: 1643-1645. PMID 18306390 DOI: 10.1002/Cncr.23352 |
0.395 |
|
| 2008 |
Shih CS, Hale GA, Gronewold L, Tong X, Laningham FH, Gilger EA, Srivastava DK, Kun LE, Gajjar A, Fouladi M. High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer. 112: 1345-53. PMID 18224664 DOI: 10.1002/Cncr.23305 |
0.472 |
|
| 2008 |
Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A. Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma International Journal of Radiation Oncology Biology Physics. 70: 782-787. PMID 17892918 DOI: 10.1016/J.Ijrobp.2007.07.2342 |
0.319 |
|
| 2007 |
Broniscer A, Gururangan S, MacDonald TJ, Goldman S, Packer RJ, Stewart CF, Wallace D, Danks MK, Friedman HS, Poussaint TY, Kun LE, Boyett JM, Gajjar A. Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6712-8. PMID 18006772 DOI: 10.1158/1078-0432.Ccr-07-1016 |
0.403 |
|
| 2007 |
Schaiquevich P, Panetta JC, Iacono LC, Freeman BB, Santana VM, Gajjar A, Stewart CF. Population pharmacokinetic analysis of topotecan in pediatric cancer patients Clinical Cancer Research. 13: 6703-6711. PMID 18006771 DOI: 10.1158/1078-0432.Ccr-07-1376 |
0.304 |
|
| 2007 |
Stewart CF, Panetta JC, O'Shaughnessy MA, Throm SL, Fraga CH, Owens T, Liu T, Billups C, Rodriguez-Galindo C, Gajjar A, Furman WL, McGregor LM. UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan Journal of Clinical Oncology. 25: 2594-2600. PMID 17577039 DOI: 10.1200/Jco.2006.10.2301 |
0.333 |
|
| 2007 |
Sanders RP, Kocak M, Burger PC, Merchant TE, Gajjar A, Broniscer A. High-grade astrocytoma in very young children. Pediatric Blood & Cancer. 49: 888-93. PMID 17554787 DOI: 10.1002/Pbc.21272 |
0.429 |
|
| 2007 |
Morris EB, Gajjar A, Okuma JO, Yasui Y, Wallace D, Kun LE, Merchant TE, Fouladi M, Broniscer A, Robison LL, Hudson MM. Survival and late mortality in long-term survivors of pediatric CNS tumors Journal of Clinical Oncology. 25: 1532-1538. PMID 17442996 DOI: 10.1200/Jco.2006.09.8194 |
0.337 |
|
| 2007 |
Palmer SL, Reddick WE, Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. Journal of Pediatric Psychology. 32: 1040-9. PMID 17329318 DOI: 10.1093/Jpepsy/Jsl056 |
0.313 |
|
| 2007 |
Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 11: 69-82. PMID 17222791 DOI: 10.1016/J.Ccr.2006.11.020 |
0.327 |
|
| 2006 |
Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: A prospective study by the Children's Oncology Group Journal of Neurosurgery. 105: 444-451. PMID 17184075 DOI: 10.3171/Ped.2006.105.6.444 |
0.408 |
|
| 2006 |
Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Cancer. 107: 2291-7. PMID 17019740 DOI: 10.1002/Cncr.22241 |
0.431 |
|
| 2006 |
Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. The Lancet. Oncology. 7: 813-20. PMID 17012043 DOI: 10.1016/S1470-2045(06)70867-1 |
0.394 |
|
| 2006 |
Shan ZY, Liu JZ, Glass JO, Gajjar A, Li CS, Reddick WE. Quantitative morphologic evaluation of white matter in survivors of childhood medulloblastoma Magnetic Resonance Imaging. 24: 1015-1022. PMID 16997071 DOI: 10.1016/J.Mri.2006.04.015 |
0.371 |
|
| 2006 |
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4202-8. PMID 16943538 DOI: 10.1200/Jco.2006.06.4980 |
0.371 |
|
| 2006 |
Gottardo NG, Gajjar A. Current therapy for medulloblastoma. Current Treatment Options in Neurology. 8: 319-334. PMID 16942675 DOI: 10.1007/S11940-006-0022-X |
0.418 |
|
| 2006 |
Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1924-31. PMID 16567768 DOI: 10.1200/Jco.2005.04.4974 |
0.302 |
|
| 2006 |
Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, Gajjar A, Mulhern RK. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. International Journal of Radiation Oncology, Biology, Physics. 65: 210-21. PMID 16472938 DOI: 10.1016/J.Ijrobp.2005.10.038 |
0.386 |
|
| 2006 |
Broniscer A, Chintagumpala M, Fouladi M, Krasin MJ, Kocak M, Bowers DC, Iacono LC, Merchant TE, Stewart CF, Houghton PJ, Kun LE, Ledet D, Gajjar A. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. Journal of Neuro-Oncology. 76: 313-9. PMID 16200343 DOI: 10.1007/S11060-005-7409-5 |
0.429 |
|
| 2006 |
Turner PK, Iacono LC, Panetta JC, Santana VM, Daw NC, Gajjar A, Stewart CF. Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in children Cancer Chemotherapy and Pharmacology. 57: 475-482. PMID 16047146 DOI: 10.1007/S00280-005-0062-Z |
0.302 |
|
| 2006 |
Fuller C, Fouladi M, Gajjar A, Dalton J, Sanford RA, Helton KJ. Chromosome 17 abnormalities in pediatric neuroblastic tumor with abundant neuropil and true rosettes. American Journal of Clinical Pathology. 126: 277-283. DOI: 10.1309/Tfbx1Lwq93Mxqbaw |
0.401 |
|
| 2005 |
Phillips NS, Sanford RA, Helton KJ, Boop FA, Zou P, Tekautz T, Gajjar A, Ogg RJ. Diffusion tensor imaging of intraaxial tumors at the cervicomedullary and pontomedullary junctions. Report of two cases. Journal of Neurosurgery. 103: 557-62. PMID 16383256 DOI: 10.3171/Ped.2005.103.6.0557 |
0.393 |
|
| 2005 |
Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 8: 323-35. PMID 16226707 DOI: 10.1016/J.Ccr.2005.09.001 |
0.324 |
|
| 2005 |
Gilbertson RJ, Gajjar A. Molecular biology of medulloblastoma: will it ever make a difference to clinical management? Journal of Neuro-Oncology. 75: 273-278. PMID 16195803 DOI: 10.1007/S11060-005-6750-Z |
0.321 |
|
| 2005 |
Fouladi M, Gilger E, Kocak M, Wallace D, Buchanan G, Reeves C, Robbins N, Merchant T, Kun LE, Khan R, Gajjar A, Mulhern R. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7152-60. PMID 16192599 DOI: 10.1200/Jco.2005.01.214 |
0.431 |
|
| 2005 |
Khan RB, Hunt DL, Boop FA, Sanford RA, Merchant TE, Gajjar A, Kun LE. Seizures in children with primary brain tumors: incidence and long-term outcome. Epilepsy Research. 64: 85-91. PMID 15941651 DOI: 10.1016/J.Eplepsyres.2005.03.007 |
0.35 |
|
| 2005 |
Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1491-9. PMID 15735125 DOI: 10.1200/Jco.2005.05.187 |
0.449 |
|
| 2005 |
Reddick WE, Glass JO, Palmer SL, Wu S, Gajjar A, Langston JW, Kun LE, Xiong X, Mulhern RK. Atypical white matter volume development in children following craniospinal irradiation. Neuro-Oncology. 7: 12-9. PMID 15701278 DOI: 10.1215/S1152851704000079 |
0.335 |
|
| 2005 |
Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R. Phase I Clinical Trial of Mafosfamide in Infants and Children Aged 3 Years or Younger With Newly Diagnosed Embryonal Tumors: A Pediatric Brain Tumor Consortium Study (PBTC-001) Journal of Clinical Oncology. 23: 525-531. PMID 15659498 DOI: 10.1200/Jco.2005.06.544 |
0.376 |
|
| 2005 |
Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer. 103: 368-76. PMID 15599932 DOI: 10.1002/Cncr.20743 |
0.351 |
|
| 2005 |
Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer. 103: 133-9. PMID 15565574 DOI: 10.1002/Cncr.20741 |
0.37 |
|
| 2004 |
Stewart CF, Iacono LC, Chintagumpala M, Kellie SJ, Ashley D, Zamboni WC, Kirstein MN, Fouladi M, Seele LG, Wallace D, Houghton PJ, Gajjar A. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor Journal of Clinical Oncology. 22: 3357-3365. PMID 15310781 DOI: 10.1200/Jco.2004.10.103 |
0.382 |
|
| 2004 |
Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncology. 5: 399-408. PMID 15231246 DOI: 10.1016/S1470-2045(04)01507-4 |
0.393 |
|
| 2004 |
Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Cancer. 100: 2246-52. PMID 15139071 DOI: 10.1002/cncr.20253 |
0.316 |
|
| 2004 |
Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist. 9: 197-206. PMID 15047924 DOI: 10.1634/Theoncologist.9-2-197 |
0.459 |
|
| 2004 |
Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L, Gilbertson RJ. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 984-93. PMID 14970185 DOI: 10.1200/Jco.2004.06.032 |
0.321 |
|
| 2003 |
Fouladi M, Helton K, Dalton J, Gilger E, Gajjar A, Merchant T, Kun L, Newsham I, Burger P, Fuller C. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer. 98: 2232-2244. PMID 14601094 DOI: 10.1002/Cncr.11783 |
0.454 |
|
| 2003 |
Palmer SL, Gajjar A, Reddick WE, Glass JO, Kun LE, Wu S, Xiong X, Mulhern RK. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology. 17: 548-55. PMID 14599268 DOI: 10.1037/0894-4105.17.4.548 |
0.385 |
|
| 2003 |
Panetta JC, Kirstein MN, Gajjar A, Nair G, Fouladi M, Heideman RL, Wilkinson M, Stewart CF. Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors Cancer Chemotherapy and Pharmacology. 52: 435-441. PMID 13680158 DOI: 10.1007/S00280-003-0670-4 |
0.361 |
|
| 2003 |
Gajjar A, Chintagumpala MM, Bowers DC, Jones-Wallace D, Stewart CF, Crews KR. Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapy. Cancer. 97: 2374-80. PMID 12712459 DOI: 10.1002/Cncr.11308 |
0.329 |
|
| 2003 |
Ellison DW, Clifford SC, Gajjar A, Gilbertson RJ. What's new in neuro-oncology? Recent advances in medulloblastoma. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 7: 53-66. PMID 12697428 DOI: 10.1016/S1090-3798(03)00014-X |
0.326 |
|
| 2003 |
Edick MJ, Gajjar A, Mahmoud HH, van de Poll ME, Harrison PL, Panetta JC, Rivera GK, Ribeiro RC, Sandlund JT, Boyett JM, Pui CH, Relling MV. Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1340-6. PMID 12663724 DOI: 10.1200/Jco.2003.06.083 |
0.34 |
|
| 2003 |
Fouladi M, Wallace D, Langston JW, Mulhern R, Rose SR, Gajjar A, Sanford RA, Merchant TE, Jenkins JJ, Kun LE, Heideman RL. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer. 97: 1084-92. PMID 12569610 DOI: 10.1002/Cncr.11119 |
0.446 |
|
| 2002 |
Helton KJ, Gajjar A, Hill DA, Boop FA, Kun LE, Langston JW. Medulloblastoma Metastatic to the Suprasellar Region at Diagnosis: A Report of Six Cases with Clinicopathologic Correlation Pediatric Neurosurgery. 37: 111-117. PMID 12187055 DOI: 10.1159/000064392 |
0.315 |
|
| 2001 |
Fouladi M, Jenkins J, Burger P, Langston J, Merchant T, Heideman R, Thompson S, Sanford A, Kun L, Gajjar A. Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-Oncology. 3: 184-92. PMID 11465399 DOI: 10.1093/Neuonc/3.3.184 |
0.359 |
|
| 2001 |
Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A. Feasibility of Four Consecutive High-Dose Chemotherapy Cycles With Stem-Cell Rescue for Patients With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor After Craniospinal Radiotherapy: Results of a Collaborative Study Journal of Clinical Oncology. 19: 2696-2704. PMID 11352962 DOI: 10.1200/Jco.2001.19.10.2696 |
0.381 |
|
| 2001 |
Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, Merchant TE, Mulhern RK. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2302-8. PMID 11304784 DOI: 10.1200/Jco.2001.19.8.2302 |
0.351 |
|
| 2001 |
Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui C, Hudson MM, Mulhern RK. Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer Journal of Clinical Oncology. 19: 1802-1808. PMID 11251012 DOI: 10.1200/Jco.2001.19.6.1802 |
0.315 |
|
| 2000 |
Reddick WE, Russell JM, Glass JO, Xiong X, Mulhern RK, Langston JW, Merchant TE, Kun LE, Gajjar A. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magnetic Resonance Imaging. 18: 787-93. PMID 11027871 DOI: 10.1016/S0730-725X(00)00182-X |
0.43 |
|
| 2000 |
Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D, Kun LE, Heideman RL. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital. Journal of Pediatric Hematology Oncology. 22: 247-251. PMID 10864056 DOI: 10.1097/00043426-200005000-00010 |
0.482 |
|
| 2000 |
Fouladi M, Langston J, Mulhern R, Jones D, Xiong X, Yang J, Thompson S, Walter A, Heideman R, Kun L, Gajjar A. Silent Lacunar Lesions Detected by Magnetic Resonance Imaging of Children With Brain Tumors: A Late Sequela of Therapy Journal of Clinical Oncology. 18: 824-824. PMID 10673524 DOI: 10.1200/Jco.2000.18.4.824 |
0.458 |
|
| 2000 |
Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk B, Relling MV, Evans WE, Boyett JM, Pui C. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia Blood. 96: 3381-3384. DOI: 10.1182/Blood.V96.10.3381.H8003381_3381_3384 |
0.377 |
|
| 1999 |
Mulhern RK, Reddick WE, Palmer SL, Glass JO, Elkin TD, Kun LE, Taylor J, Langston J, Gajjar A. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Annals of Neurology. 46: 834-41. PMID 10589535 DOI: 10.1002/1531-8249(199912)46:6<834::Aid-Ana5>3.0.Co;2-M |
0.402 |
|
| 1999 |
Walter AW, Mulhern RK, Gajjar A, Heideman RL, Reardon D, Sanford RA, Xiong X, Kun LE. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 3720-8. PMID 10577843 DOI: 10.1200/Jco.1999.17.12.3720 |
0.364 |
|
| 1999 |
Gajjar A, Fouladi M, Walter AW, Thompson SJ, Reardon DA, Merchant TE, Jenkins JJ, Liu A, Boyett JM, Kun LE, Heideman RL. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 1825-8. PMID 10561221 DOI: 10.1200/Jco.1999.17.6.1825 |
0.396 |
|
| 1999 |
Gajjar A, Kühl J, Epelman S, Bailey C, Allen J. Chemotherapy of medulloblastoma. Childs Nervous System. 15: 554-562. PMID 10550586 DOI: 10.1007/S003810050543 |
0.357 |
|
| 1999 |
Fouladi M, Gajjar A, Boyett JM, Walter AW, Thompson SJ, Merchant TE, Jenkins JJ, Langston JW, Liu A, Kun LE, Heideman RL. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 3234-7. PMID 10506624 DOI: 10.1200/Jco.1999.17.10.3234 |
0.335 |
|
| 1999 |
Strother D, Bowman L, Fraga A, Benain E, Ashley D, Kellie S, Kun L, Shearer P, Gajjar A. #415 High-dose chemotherapy and peripheral blood stem cell rescue following craniospinal irradiation is feasible for patients for medulloblastoma Journal of Pediatric Hematology Oncology. 21: 325. DOI: 10.1097/00043426-199907000-00084 |
0.306 |
|
| 1998 |
Reardon DA, Gajjar A, Sanford RA, Heideman RL, Walter AW, Thompson SJ, Merchant TE, Li H, Jenkins JJ, Langston J, Boyett JM, Kun LE. Bithalamic involvement predicts poor outcome among children with thalamic glial tumors. Pediatric Neurosurgery. 29: 29-35. PMID 9867348 DOI: 10.1159/000028681 |
0.435 |
|
| 1998 |
Walter AW, Shearer PD, Pappo AS, Greenwald CA, Rao BN, Bowman LC, Furman WL, Gajjar A, Jenkins JJ, Pratt CB. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Medical and Pediatric Oncology. 30: 210-6. PMID 9473755 DOI: 10.1002/(Sici)1096-911X(199804)30:4<210::Aid-Mpo2>3.0.Co;2-J |
0.464 |
|
| 1998 |
Walter AW, Gajjar A, Ochs JS, Langston JW, Sanford RA, Kun LE, Heideman R. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: A phase I/II study Medical and Pediatric Oncology. 30: 28-33. PMID 9371386 DOI: 10.1002/(Sici)1096-911X(199801)30:1<28::Aid-Mpo9>3.0.Co;2-2 |
0.423 |
|
| 1998 |
Bowman LC, Williams R, Sanders M, Ringwald-Smith K, Baker D, Gajjar A. Algorithm for nutritional support: experience of the Metabolic and Infusion Support Service of St. Jude Children's Research Hospital. International Journal of Cancer. 78: 76-80. DOI: 10.1002/(Sici)1097-0215(1998)78:11+<76::Aid-Ijc22>3.0.Co;2-1 |
0.31 |
|
| 1997 |
Sanford RA, Kun LE, Heideman RL, Gajjar A. Cerebellar pontine angle ependymoma in infants Pediatric Neurosurgery. 27: 84-91. PMID 9520080 DOI: 10.1159/000121232 |
0.384 |
|
| 1997 |
Hartsell WF, Gajjar A, Heideman RL, Langston JA, Sanford RA, Walter A, Jones D, Chen G, Kun LE. Patterns of failure in children with medulloblastoma: Effects of preirradiation chemotherapy International Journal of Radiation Oncology Biology Physics. 39: 15-24. PMID 9300735 DOI: 10.1016/S0360-3016(97)00136-3 |
0.376 |
|
| 1997 |
Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, Langston JW, Muhlbauer M, Boyett JM, Kun LE. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 2792-9. PMID 9256121 DOI: 10.1200/Jco.1997.15.8.2792 |
0.462 |
|
| 1997 |
Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D, Kun LE, Taylor J. Brain Stem Involvement in Children with Neurofibromatosis Type 1: Role of Magnetic Resonance Imaging and Spectroscopy in the Distinction from Diffuse Pontine Glioma Journal of Neuro-Ophthalmology. 17: 286. DOI: 10.1097/00041327-199712000-00040 |
0.307 |
|
| 1996 |
Gajjar A, Sanford RA, Bhargava R, Heideman R, Walter A, Li Y, Langston JW, Jenkins JJ, Muhlbauer M, Boyett J, Kun LE. Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatric Neurosurgery. 25: 182-7. PMID 9293545 DOI: 10.1159/000121121 |
0.399 |
|
| 1996 |
Stewart CF, Zamboni WC, Crom WR, Gajjar A, Heideman RL, Furman WL, Meyer WH, Houghton PJ, Pratt CB. Topoisomerase I interactive drugs in children with cancer Investigational New Drugs. 14: 37-47. PMID 8880392 DOI: 10.1007/Bf00173681 |
0.366 |
|
| 1996 |
Mathew P, Look T, Luo X, Ashmun R, Nash M, Gajjar A, Walter A, Kun L, Heideman RL. DNA index of glial tumors in children. Correlation with tumor grade and prognosis. Cancer. 78: 881-6. PMID 8756385 DOI: 10.1002/(SICI)1097-0142(19960815)78:4<881::AID-CNCR27>3.0.CO;2-Q |
0.321 |
|
| 1996 |
Ashley DM, Meier L, Kerby T, Zalduondo FM, Friedman HS, Gajjar A, Kun L, Duffner PK, Smith S, Longee D. Response of recurrent medulloblastoma to low-dose oral etoposide. Journal of Clinical Oncology. 14: 1922-1927. PMID 8656261 DOI: 10.1200/Jco.1996.14.6.1922 |
0.38 |
|
| 1995 |
Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Human Gene Therapy. 6: 1231-1255. PMID 8527482 DOI: 10.1089/Hum.1995.6.9-1231 |
0.384 |
|
| 1995 |
Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, Walter AW, Kuttesch JF, Muhlbauer M, Kun LE. Low-grade astrocytoma with neuraxis dissemination at diagnosis. Journal of Neurosurgery. 83: 67-71. PMID 7782852 DOI: 10.3171/Jns.1995.83.1.0067 |
0.423 |
|
| 1995 |
Heideman RL, Kovnar EH, Kellie SJ, Douglass EC, Gajjar AJ, Walter AW, Langston JA, Jenkins JJ, Li Y, Greenwald C. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 2247-54. PMID 7666082 DOI: 10.1200/JCO.1995.13.9.2247 |
0.318 |
|
| 1994 |
Gajjar A, Mulhern RK, Heideman RL, Sanford RA, Douglass EC, Kovnar EH, Langston JA, Jenkins JJ, Kun LE. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 12: 1212-6. PMID 8201384 DOI: 10.1200/Jco.1994.12.6.1212 |
0.399 |
|
| 1993 |
Gajjar A, Heideman RL, Kovnar EH, Langston JA, Sanford RA, Douglass EC, Jenkins JJ, Horowitz ME, Kun LE. Response of pediatric low grade gliomas to chemotherapy. Pediatric Neurosurgery. 19: 113-8; discussion 11. PMID 8499323 DOI: 10.1159/000120714 |
0.35 |
|
| Show low-probability matches. |